Liquid transfer device with dual lumen IV spike

Information

  • Patent Grant
  • 11786442
  • Patent Number
    11,786,442
  • Date Filed
    Monday, September 26, 2022
    2 years ago
  • Date Issued
    Tuesday, October 17, 2023
    a year ago
Abstract
A liquid transfer device includes a vial adapter that receives a vial. The vial adapter includes a vial spike that punctures a vial stopper of the vial and defines a vial spike lumen. The liquid transfer device also includes an intravenous (IV) port that receives a port spike of an infusion set. The liquid transfer device also includes a connector body including a vial adapter lumen in fluid communication with the vial spike lumen, a barrel connected to the IV port, and an IV spike including a central wall. The central wall defines a first IV spike lumen in fluid communication with the vial adapter lumen and a second IV spike lumen in fluid communication with the IV port. The first IV spike lumen and the second IV spike lumen are separated by the central wall.
Description
BACKGROUND OF THE DISCLOSURE

The present disclosure is generally directed to liquid transfer devices.


Conventional infusion liquid containers containing an infusion liquid to be delivered to a patient generally take the form of an infusion liquid bag, an infusion liquid bottle, and the like. A pre-filled syringe or vial is generally utilized to add a high concentration of a drug to the infusion liquid contents, via a liquid transfer device, to form a diluted, medicated infusion liquid. Thereafter, an infusion set including an IV spike may be inserted into an IV port of the liquid transfer device for infusion of medicated infusion liquid contents to a patient. Minimizing the risk of a patient receiving a portion of the drug in a highly concentrated, undiluted form is important for patient safety.


BRIEF SUMMARY OF THE DISCLOSURE

The present disclosure realizes the advantageous manufacture of a liquid transfer device having separate lumens: one for mixing the high concentration of drug with the infusion liquid, and one for transferring the diluted, medicated infusion liquid to the infusion set, as an added measure to prevent the patient from receiving a portion of the drug in an undiluted, high concentration form. The present disclosure additionally or alternatively realizes the advantageous manufacture of a liquid transfer device capable of mixing the fluid within the lumen between the IV port and the port connected to the medicated infusion liquid contents prior to administering the medicated infusion liquid contents to a patient.


Briefly stated, one aspect of the present disclosure is directed to a liquid transfer device configured for use with each of an infusion liquid container containing an infusion liquid and having an intravenous (IV) port for administering the infusion liquid, a vial containing a medicament additive sealed by a vial stopper, and an infusion set including an IV spike for sealing insertion into an IV port and a connector, such as an infusion set, for administration purposes to a patient. The liquid transfer device includes a monolithic trifurcated connector body defining a barrel at a first end thereof, a single IV spike at a second end thereof and a vial adapter lumen at a third end thereof. An IV port is connected to the barrel and configured to sealingly receive the IV spike of the infusion set. A vial adapter is permanently secured to the vial adapter lumen and configured to telescopically mount onto the vial. The vial adapter includes a vial spike fluidly connected with the vial adapter lumen and configured to puncture the vial stopper upon mounting of the vial adapter onto the vial for flow communication therewith. The single IV spike is configured to sealingly insert into the IV port of the infusion liquid container. The single IV spike has a first IV spike lumen fluidly connected at a proximal end thereof with only the vial adapter lumen via the trifurcated connector body and a second IV spike lumen fluidly connected at a proximal end thereof with only the IV port via the trifurcated connector body, thereby separating fluid communication between the vial adapter and the single IV spike from fluid communication between the IV port and the single IV spike while enabling initial introduction of the medicament additive from the vial to the infusion liquid container through the vial adapter and the first IV spike lumen for mixing with the infusion liquid to form a medicated infusion liquid, and enabling subsequent administration of the medicated infusion liquid to a patient from the infusion liquid container through the second IV spike lumen and the IV port to the infusion set. The first IV spike lumen has a first peripherally disposed distal aperture and the second IV spike lumen has a second peripherally disposed distal aperture.


Briefly stated, another aspect of the present disclosure is directed to a method of using a liquid transfer device having a monolithic trifurcated connector body defining a barrel at a first end thereof, a single intravenous (IV) spike at a second end thereof and a vial adapter lumen at a third end thereof. The method includes the steps of mounting a vial adapter permanently secured to the vial adapter lumen onto a vial containing a medicament additive, and, in turn, piercing a stopper of the vial with a vial spike of the vial adapter fluidly connected with the vial adapter lumen; piercing an IV port of an infusion liquid container containing an infusion liquid with the single IV spike; and adding the medicament additive within the vial to the infusion liquid within the infusion liquid container (i.e. mixing the medicament with the infusion liquid) to obtain a medicated infusion liquid via the vial adapter lumen and a first IV spike lumen of the single IV spike. The first IV spike lumen is fluidly connected at a proximal end thereof with only the vial adapter lumen via the trifurcated connector body and has a first peripherally disposed distal aperture proximate a distal end of the single IV spike. The method also includes the step of inserting an IV spike of an infusion set into an IV port of the liquid transfer device, the IV port of the liquid transfer device being fluidly connected to a second IV spike lumen of the single IV spike. The second IV spike lumen is fluidly connected at a proximal end thereof with only the IV port and has a second peripherally disposed distal aperture proximate the distal end of the single IV spike, thereby fluidly connecting the infusion set with the infusion liquid container for administration of the medicated infusion liquid to a patient.





BRIEF DESCRIPTION OF THE DRAWINGS

The following detailed description of aspects of the disclosure will be better understood when read in conjunction with the appended drawings. It should be understood, however, that the disclosure is not limited to the precise arrangements and instrumentalities shown. In the drawings:



FIG. 1A is a front elevational view of an infusion liquid container in the form of a bag usable with a liquid transfer device according to the present disclosure;



FIG. 1B is a front elevational view of an infusion liquid container in the form of a flexible bottle usable with a liquid transfer device according to the present disclosure;



FIG. 1C is a front elevational view of a pre-filled needleless syringe and a vial usable with the liquid transfer device according to the present disclosure;



FIG. 1D is a front elevational view of an infusion set usable with the liquid transfer device according to the present disclosure;



FIG. 2A is a perspective view of the liquid transfer device, in accordance with a first embodiment of the present disclosure, in a depressed plunger configuration;



FIG. 2B is a cross-sectional elevational view of the liquid transfer device of FIG. 2A, taken along sectional line 2B-2B of FIG. 2A;



FIG. 3 is a perspective view of the syringe plunger and an IV port of the liquid transfer device of FIG. 2A;



FIG. 4A is a perspective view of the liquid transfer device according to the present disclosure, in a withdrawn plunger configuration;



FIG. 4B is a cross-sectional elevational view of the liquid transfer device of FIG. 4A, taken along sectional line 4B-4B of FIG. 4A;



FIG. 5 is a cross-sectional elevational view of another embodiment of a liquid transfer device having an alternatively configured IV spike;



FIG. 6 is a cross-sectional elevational view of the liquid transfer device of FIG. 2A, taken along sectional line 2B-2B of FIG. 2A, having another alternatively configured IV spike;



FIG. 7A is an enlarged cross-sectional elevational view of one configuration of a vial adapter of the liquid transfer device of FIG. 2A;



FIG. 7B is an enlarged cross-sectional elevational view of another configuration of a vial adapter of the liquid transfer device of FIG. 2A;



FIG. 8 is a perspective view of a liquid transfer device, in accordance with a second embodiment of the present disclosure;



FIG. 9 is a cross-sectional elevational view of the liquid transfer device of FIG. 8, taken along sectional line 9-9 of FIG. 8; and



FIG. 10 is an enlarged partial, exploded, perspective view of an alternative attachment between a trifurcated connector body and an elongate connecting member, such as an IV port, of the liquid transfer device of FIG. 8.



FIGS. 11A and 11B are cross-sectional elevational views of another embodiment of the liquid transfer device of FIG. 6 having an internal valve.





DETAILED DESCRIPTION OF THE DISCLOSURE

Certain terminology is used in the following description for convenience only and is not limiting. The words “lower,” “bottom,” “upper” and “top” designate directions in the drawings to which reference is made. The words “inwardly,” “outwardly,” “upwardly” and “downwardly” refer to directions toward and away from, respectively, the geometric center of the liquid transfer device, and designated parts thereof, in accordance with the present disclosure. Unless specifically set forth herein, the terms “a,” “an” and “the” are not limited to one element, but instead should be read as meaning “at least one.” The terminology includes the words noted above, derivatives thereof and words of similar import.


It should also be understood that the terms “about,” “approximately,” “generally,” “substantially” and like terms, used herein when referring to a dimension or characteristic of a component of the disclosure, indicate that the described dimension/characteristic is not a strict boundary or parameter and does not exclude minor variations therefrom that are functionally similar. At a minimum, such references that include a numerical parameter would include variations that, using mathematical and industrial principles accepted in the art (e.g., rounding, measurement or other systematic errors, manufacturing tolerances, etc.), would not vary the least significant digit.


Referring to the drawings in detail, wherein like numerals indicate like elements throughout, there is shown in FIGS. 2A-6 a liquid transfer device 30, in accordance with a first embodiment of the present disclosure, intended for use with the combination of infusion liquid containers containing an infusion liquid and additive transfer devices. In the illustrated embodiment, the liquid transfer device 30 is intended for use with an infusion liquid container in the form of an infusion liquid bag 10 (FIG. 1A). As should be understood by those of ordinary skill in the art, a conventional infusion liquid bag 10 includes a reservoir 12 containing infusion liquid, in fluid communication with an intravenous administration port 14 and an additive port 16. The infusion liquid bag 10 is collapsible upon administration of the infusion liquid therefrom. The liquid transfer device 30 may also be used with an infusion liquid container in the form of a flexible infusion liquid bottle 18 (FIG. 1B) or the like. The liquid transfer device 30 of the illustrated embodiment is also intended for use with an additive transfer device in the form of a sealed vial 20 (FIG. 1C). The vial 20 generally contains a highly concentrated medicament liquid additive or a lyophilized powder drug requiring reconstitution prior to administration to a patient, i.e., requiring mixing with the infusion liquid in the bag 10 to form a medicated infusion liquid administered to a patient. The contents of the vial 20 are, therefore, introduced into the infusion liquid bag 10 via the liquid transfer device 30 (as will be described in further detail below). The liquid transfer device 30 may also, however, take a different configuration intended for use with a syringe 22 (FIG. 1C) containing a medicament liquid additive.


The liquid transfer device 30 includes a trifurcated connector body 32. In the illustrated embodiment of FIGS. 2A-6, the trifurcated connector body 32 is a monolithic body defining a barrel 34 at a first end thereof, a single IV spike 36 at a second end thereof, and a vial adapter 38 at a third end thereof, but the disclosure is not so limited (as described further below). As shown best in FIGS. 2B, 4B and 5, the barrel 34 defines an internal chamber 34a having an open proximal end 34b for slidably receiving a plunger 40 (as will be described further below). The IV spike 36 defining the second end of the trifurcated body 32 enables use of the liquid transfer device 30 with infusion liquid bags 10, i.e., for sealingly inserting the IV spike 36 into the administration port 14 of the bag 10. The IV spike 36 may be constructed from a suitable rigid metal, polymeric or plastic material, such as, for example, polycarbonate and the like. A flange 33 extends laterally from the IV spike 36 proximate a proximal end thereof to provide a gripping or bearing surface to enable a user to more easily insert the IV spike 36 into a liquid container, such as bag 10. The IV spike may optionally include a feature, such as raised step 35 around the circumferential surface of the IV spike 36, for restricting insertion depth into the administration port 14 of the bag 10. In one embodiment, the flange 33 may also be formed as an injection molded monolithic structure with the connector body 32, but the disclosure is not so limited. A spike cap (not shown) may removably cover the IV spike 36 when not in use.


As shown, the IV spike 36 is co-directional and/or coaxial with the barrel 34 and includes two internal lumens 36a, 36b. In the illustrated configurations, the lumens 36a, 36b extend generally parallel to one another. The first IV spike lumen 36a is continuously and directly fluidly connected at a proximal end with only a vial adapter lumen 37 located within the vial adapter 38 angularly bifurcating from, i.e., branching off of, the IV spike 36. The first IV spike lumen 36a includes a first peripherally disposed distal-facing distal aperture 36c extending through a tapered distal tip 36e of the IV spike 36. As shown best in FIGS. 2B, 4B and 5, the first IV spike lumen 36a is not fluidly connected at the proximal end thereof with the barrel chamber 34a. The second IV spike lumen 36b is directly fluidly connectable at a proximal end with only the barrel chamber 34a and includes a second peripherally disposed side-facing distal aperture 36d, separate from the first distal aperture 36c of the first IV spike lumen 36a. The second IV spike lumen 36b is not fluidly connected at the proximal end thereof with the vial adapter lumen 37 or at any point along the length of the IV spike 36. In other words, IV spike 36 includes two separate lumens 36a, 36b that extend through the IV spike 36 to provide discrete fluid paths that are not connected within the IV spike 36 being separated by a central wall 36f having a transverse protrusion 36g. Thus, fluid communication between the vial adapter 38 and the IV spike 36 is separate from fluid communication between the barrel chamber 34a and the IV spike 36.


The vial adapter 38 is configured to mount onto a vial 20 to enable usage of the device 30 with an additive transfer device in the form of a vial 20. In one configuration, the vial adapter 38 may be integrally formed at the third end of the connector body 32, i.e., monolithically formed with the terminal end of the vial adapter lumen 37 or otherwise permanently secured and sealed to the terminal end of the vial adapter lumen 37, but the disclosure is not so limited. As used herein through the specification and the claims, “permanently secured” means not disconnectable/removable without causing damage to the device or portion thereof. As one non-limiting example, the vial adapter 38 may be ultrasonically welded to the vial adapter lumen 37.


Referring to FIG. 7A, the vial adapter 38 includes a top wall 38d, a flexible and/or flared skirt 38a depending therefrom for telescopic snap fit mounting onto a vial 20 (in a standard manner) and a vial spike 38b for puncturing the vial 20, e.g., through a stopper thereof, to fluidly communicate with the interior of the vial 20. The puncturing vial spike 38b includes a lumen 38c in fluid communication with the vial adapter lumen 37, and, in turn with the first IV spike lumen 36a. As should be understood by those of ordinary skill in the art, the inner diameter of the vial spike 38b, i.e., the diameter of the lumen 38c, and/or the outer diameter of the vial spike 38b may be dimensioned as appropriate for the intended use.


In the configuration of FIG. 7A, the vial spike 38b includes a base section 39 that is generally concave with respect to the axis of the vial spike 38b. The vial adapter 38 may alternatively be configured to minimize/protect against leakage resulting from the tear that forms in the stopper of a vial 20 as the vial adapter 38 is pushed down onto the vial 20 and the vial spike 38b advances through the stopper. As illustrated in the configuration of FIG. 7B, the direction of extension of the base section 39′ is generally convex with respect to the axis of the vial spike 38b such that the base section 39′ has a generally bulbous configuration. When the vial adapter 38 is pushed down onto the vial 20 and the spike 38b advances through the vial stopper, the base section 39′ is compressed against an upper surface of the vial stopper and the compressed material of the vial stopper surrounds tears formed in the vial stopper for sealing thereof. Puncturing of the vial stopper by the vial spike 38b is generally accompanied by the formation of a depression in the upper surface of the vial stopper. The convex base section 39′ is configured to fill in the depression, thereby minimizing/protecting against leakage. As should be understood by those of ordinary skill in the art, however, different sealing base sections/means, currently known, or that later become known, may be employed to minimize leakage between the vial spike 38b and the elastic stopper of vial 20. As also should be understood, other vial adapter configurations, currently known, or that later become known, may alternatively be employed.


Turning to the plunger 40, as shown best in FIGS. 2B, 3, 4B and 5, the plunger 40 includes an upright plunger tube 46, defining a plunger tube lumen 46a therein. The plunger tube 46 is slidably engaged with the barrel 34 via a peripheral sealing member 42 (constructed, for example, of an elastomeric material or the like) interposed therebetween in a manner well understood by those of ordinary skill in the art, permitting sliding within the barrel 34 while creating a substantially air-tight seal between the plunger tube 46 and the interior sidewall of the barrel 34. The plunger tube 46 and the sealing member 42, in combination with the barrel 34, define a sealed proximal end of the barrel chamber 34a. The plunger tube 46 includes a distal, elongate neck portion 44 terminating in a check valve 48. In the illustrated embodiment, the check valve 48 takes the form of a duckbill valve, constructed of an elastomeric material or the like, but the disclosure is not so limited. For example, without limitation, the check valve 48 may take the form of several other types of one-way valves, such as, for example, a ball valve, a silicone flapper valve, a diaphragm-type valve, an in-line valve, a stop-check valve, a lift-check valve, or the like, capable of performing the functions of the check valve 48 described herein.


As shown, an IV port 50 is fluidly connected with a proximal end of the plunger tube 46. The IV port 50 includes a twist-off member 50a proximate a peripheral, free proximal end of the port 50, and an elongate connecting member 52 projecting distally therefrom, having an internal lumen 52a extending therethrough and terminating in an open end (opposite end from the twist-off member 50a). The internal lumen 52a of the IV port 50 extends co-directionally and/or coaxially with the plunger lumen 46a. In one embodiment, the IV port 50 may be constructed from a suitable flexible polymeric or plastic material, such as, for example, PVC, and the like. In the illustrated embodiment, the elongate connecting member 52 is adhered, i.e., adhesively bonded, with the plunger tube 46, but the disclosure is not so limited. For example, without limitation, the elongate connecting member 52 may be permanently secured and rotationally fixedly attached to the plunger tube 46 (for example, as described in further detail below with respect to FIGS. 8 to 10).


The IV port 50 includes a septum 50b positioned within the elongate connecting member 52, sealing across the internal lumen 52a. Accordingly, the twist-off member 50a may be removed without leading to flow communication beyond the septum 50b. Flow communication beyond the septum 50b, i.e., with the plunger lumen 46a and beyond, is only achieved upon puncturing the septum 50b (as described in further detail below). The twist off member 50a keeps the IV port 50, and particularly the septum 50b, sterile until use.


In use, the liquid transfer device 30 may be coupled to an infusion liquid bag 10 via the IV spike 36 (as previously described). Thereafter, the user withdraws the plunger 40 in a proximal direction, i.e., in a direction away from the IV spike 36 (FIGS. 4A, 4B). Alternatively, a dedicated handle may be employed and attached to the plunger 40 for translation thereof. Withdrawal of the plunger 40, with the distal aperture 36d immersed in the infusion liquid within the bag 10, pulls fluid from the bag 10, through the distal aperture 36d, through the second IV spike lumen 36b and into the barrel chamber 34a. The duckbill valve 48 is configured to prevent fluid flow into the plunger tube lumen 46a during plunger 40 withdrawal. As should be understood by those of ordinary skill in the art, withdrawal of the plunger 40 creates a vacuum in the barrel chamber 34a, resulting in a pressure difference relative to the infusion liquid bag 10, thereby pulling the fluid into the barrel chamber 34a. As also should be understood, the infusion liquid remains within the barrel chamber 34a and the second IV spike lumen 36b until manually ejected, in a manner well understood by those of ordinary skill in the art, as will be described below.


Prior or subsequent to withdrawing infusion liquid from the infusion liquid bag 10 into the barrel chamber 34a, the liquid transfer device 30 may be coupled to a vial 20 via the vial adapter 38 (as previously described). A user may mix/combine the contents within the vial 20 with the contents within the infusion liquid bag 10 via the vial adapter lumen 37 and the first IV spike lumen 36a by inverting the infusion liquid bag 10 and the liquid transfer device 30, i.e., positioning the vial 20 above the bag 10, so that the contents of the vial 20 drain into the infusion liquid bag 10. Where the vial 20 contains a lyophilized powder drug, the drug can be reconstituted in a similar fashion. After coupling the vial 20 to the liquid transfer device 30, the liquid bag 10 is held above the vial 20, so that liquid from the liquid bag 10 drains into the vial 20 and reconstitutes the contents of the vial 20. The infusion liquid bag 10 and the liquid transfer device 30 may then be inverted, as previously described, to drain the reconstituted contents of the vial 20 into the bag 10.


After mixing/combining the contents within the infusion liquid bag 10 and the vial 20 and orienting the liquid transfer device 30 such that the combined liquid flows into the infusion liquid bag 10, the plunger 40 is depressed until at least portion of the duckbill valve 48 engages the proximal end/rim of the second IV spike lumen 36b. In the illustrated embodiment, at least one of the elastomeric lips/flaps of the duckbill valve 48 abuts, and is displaced/compressed by, the proximal end 41 of the second IV spike lumen 36b, thereby opening the duckbill valve 48 for fluid-flow therethrough. That is, sustained pressure applied onto at least one of the elastomeric lips/flaps of the duckbill valve 48, resulting from the depression of the plunger 40 to a position engaging the valve 48 with the proximal end/rim 41 of the second IV spike lumen 36b, displaces the elastomeric lips/flaps of the valve 48 from one another, thereby breaking the seal therebetween and permitting fluid flow therethrough. Thereafter, the twist-off member 50a is removed (in a manner well understood) to provide access to the internal lumen 52a. An IV port spike 96 of an infusion set 95 (FIG. 1D) is sealingly inserted into the internal lumen 52a and fully penetrates the septum 50b, thereby fluidly connecting the IV port spike 96 with any remainder of the internal lumen 52a beyond the septum 50b, and, in turn, with the plunger lumen 46a and the second IV spike lumen 36b (via the open duckbill valve 48) for administration of the medicated infusion liquid to a patient. The IV port spike 96 typically extends from an end of a drip chamber 97a of the infusion set 95. Conventionally, an infusion set 95 additionally includes a roller clamp 97c for controlling fluid administration to a patient, a male Luer connector 97d, and tubing 97b to fluidly connect the roller clamp 97c to the drip chamber 97a.


Advantageously, the medicated infusion liquid is fluidly connected to the infusion set 95 via the second IV spike lumen 36b rather than the first IV spike lumen 36a, which is utilized only to admix the highly concentrated drug additive within the vial 20 with the infusion liquid within the bag 10. Thus, the possibility of administering a portion of the drug additive in an undiluted, high concentration form to a patient is minimized. Moreover, as the plunger 40 is depressed (as previously described), infusion liquid within the barrel chamber 34a is ejected through the second IV spike lumen 36b and out the distal aperture 36d. Therefore, after utilizing the liquid transfer device 30 to admix the contents within the infusion liquid bag 10 and the vial 20, the second IV spike lumen 36b and the distal aperture 36d thereof, though not utilized for mixing, are nevertheless flushed out prior to use thereof for transferring the medicated infusion liquid from the bag 10 to the infusion set 95, to further minimize the possibility of administering a portion of the drug additive in an undiluted, high concentration form to a patient.


In an alternative configuration, as shown in FIG. 5, a distal end of the IV spike 36′ is configured such that the first IV spike lumen 36a′ extends further distally than the second IV spike lumen 36b′. Advantageously, therefore, the first distal aperture 36c′ is separated by a distance “d” from the distal aperture 36d′, thereby further minimizing the opportunity for a portion of the drug in an undiluted, high concentration form from exiting the first distal aperture 36c′ and entering the distal aperture 36d′. The distance “d” is preferably greater than or equal to about 1.0 mm, more preferably greater than or equal to about 2.5 mm, and most preferably greater than or equal to about 4.0 mm.


In another alternative configuration, as shown in FIG. 6, the IV spike 36″ may include a single lumen 36a″ with a single distal aperture 36c″. This configuration operates in a similar manner as with the configuration shown in FIGS. 2-4B, except that withdrawing/ejecting fluid from or into the barrel chamber 34a and mixing the drug with fluid occurs in part through a common portion of the single lumen 36a″. Flushing of the lumen 36a″, as previously described, is performed between the steps of mixing/combining the contents within the infusion liquid bag 10 and the vial 20, and removing the twist-off member 50a for connection of the infusion set 95.


In a preferred embodiment illustrated in FIGS. 11A and 11B, a flow control valve 43 may be incorporated in the device, such that rotation of the flow control valve 43 allows a user to selectively fluidly connect either the vial adapter lumen 37 or the barrel chamber 34a with the single lumen 36a″. The valve 43 may prevent any highly concentrated drug additive within the vial 20 from being drawn into the barrel chamber 34a when the plunger tube 46 is withdrawn, as illustrated in FIG. 11A. Prior to mixing the contents of the vial 20 into the bag 10, the valve 43 may be rotated in order to provide a fluid connection between the vial adapter lumen 37 and the single lumen 36a″, as well as seal off the barrel chamber 34a, as illustrated in FIG. 11B. In order to flush the volume of liquid within the single lumen 36a″, the valve 43 may be rotated back to its original position in FIG. 11A prior to depressing the plunger tube 46.


In another alternative embodiment, the vial adapter 38 may be detachable. For example, the device may be provided with a valve, such as the needleless additive control valve disclosed in U.S. Pat. No. 8,551,067, the contents of which are incorporated by reference herein. The valve would allow the vial adapter 38 to be detached prior to withdrawing the plunger tube 46. The vial adapter 38 and vial 20 would then be connected via the valve to empty the highly concentrated contents of the vial 20 into the bag 10 followed by depression of the plunger tube 46 to flush the single lumen 36a″.



FIGS. 8-10 illustrate a second embodiment of the liquid transfer device 130. The reference numerals of the second embodiment are distinguishable from those of the above-described first embodiment configurations (FIGS. 2A-7B) by a factor of one-hundred (100), but otherwise indicate the same elements as indicated above, except as otherwise specified. The liquid transfer device 130 of the present embodiment is similar to that of the first embodiment configurations. Therefore, the description of certain similarities and modes of operation between the embodiments may be omitted herein for the sake of brevity and convenience, and, therefore, is not limiting.


One difference of the liquid transfer device 130 over the liquid transfer device 30 pertains to the configuration of the first end of connector body 132. As shown in FIGS. 8 and 9, the plunger 40 is removed and the IV port 150 is directly and permanently secured and sealed to the barrel 134, i.e., not disconnectable/removable without causing damage to at least one of the IV port 150 or the barrel 134 or otherwise to the device 130. Accordingly, the second IV spike lumen 136b of the single IV spike 136 is in direct and continuous fluid communication at a proximal end with only the internal lumen 152a of the elongate connecting member 152 of the IV port 150, while remaining not fluidly connected at the proximal end thereof with the vial adapter lumen 137. The first IV spike lumen 136a of the single IV spike 136 also remains continuously and directly fluidly connected at a proximal end with only the vial adapter lumen 137 and not fluidly connected at the proximal end thereof with the internal lumen 152a of the elongate connecting member 152.


In the illustrated embodiment of FIGS. 8 and 9, the elongate connecting member 152 is adhered, i.e., adhesively bonded, with the barrel 134. As previously noted, the elongate connecting member 152 may be permanently secured attached to the barrel 134. For example, as shown in FIG. 10, the barrel 134 may terminate in a barbed fitting member 154 having an open end 154a. The barbed fitting member 154 may be configured, i.e., size, dimension, material, relative to the internal diameter and material of the elongate connecting member 152 to advance into the internal lumen 152a and form a barbed, friction, i.e., interference, fit therebetween. As should be understood by those of ordinary skill in the art, the orientation of the barbed fitting member 154 permits advancement thereof into the internal lumen 152a to sealingly and securely mount the IV port 150 co-directionally upon the barrel 134 of the connector body 132, and also substantially prevent withdrawal of the barbed fitting member 154 without damaging at least one of the elongate connecting member 152 and the barbed fitting member 154.


As shown, the barbed fitting member 154 is frustoconically shaped, having a progressively increasing diameter in a direction away from the open end 154a. An opposing end of the barbed fitting member 154 defines a greater diameter from the underlying portion of the barrel 134, resulting in an annular rib 156 that provides an interference fit with the interior sidewall of the elongate connecting member 152, upon attempted withdrawal of the barbed fitting member 154 out of the elongate connecting member 152. Accordingly, the barbed fitting member 154 is advanceable into the internal lumen 152a of the elongate connecting member 152 during assembly, and, thereafter, is not readily able to be withdrawn without causing damage.


Additionally, the rim of the elongate connecting member 152 defining an open end 152b thereof includes at least one cutout 158a, and the barrel 134 includes a corresponding at least one radial tab 158b protruding from the barrel 134 and configured to mate with the at least one cutout 158a. In the illustrated embodiment, the elongate connecting member 152 includes a plurality of angularly spaced cutouts 158a, and the barrel 134 includes a corresponding plurality of angularly spaced tabs 158b. The tab(s) 158b mates with the cutout(s) 158a during mounting of the IV port 150 upon the barbed fitting member 154 of the barrel 134, to rotationally fix the IV port 150 relative to the remainder of the liquid transfer device 130. The tab(s) 158b also prevent relative rotation between the barrel 134 and the elongate connecting member 152 and enable a twist-off member 150a to be removed, as noted below, prior to connection to the infusion set 95.


In use, the liquid transfer device 130 may be coupled to a vial 20 via the vial adapter 138 and the user may mix/combine the contents within the vial 20 with the contents within the infusion liquid bag 10, via the vial adapter lumen 137 and the first IV spike lumen 136a. After mixing/combining the contents within the infusion liquid bag 10 and the vial 20 and orienting the liquid transfer device 130 such that the combined liquid flows into the infusion liquid bag 10, the twist-off member 150a is removed (in a manner well understood) to provide access to the internal lumen 152a and the IV port spike 96 of an infusion set 95 (FIG. 1D) is sealingly inserted into the internal lumen 152a and fully penetrates the septum 150b, thereby fluidly connecting the IV port spike 96 with any remainder of the internal lumen 152a beyond the septum 150b, and, in turn, with the second IV spike lumen 136b for administration of the medicated infusion liquid to a patient.


It will be appreciated by those skilled in the art that changes could be made to the embodiments described above without departing from the broad inventive concepts thereof. For example, instead of a vial adapter, the trifurcated connector body 32, 134 may include a normally closed (NC) needleless additive port (not shown) at the third end thereof (enabling selection of use with a syringe 22 or with a vial 20). As another example, the vial adapter 38, 138 can be replaced by a manually operated stop cock, and the like. As yet another example, the liquid transfer device 30 may include a locking mechanism to stabilize and/or lock the plunger 40 in the different positions thereof. It is understood, therefore, that this invention is not limited to the particular embodiments disclosed, but it is intended to cover modifications within the spirit and scope of the present disclosure, as set forth in the appended claims.

Claims
  • 1. A liquid transfer device comprising: a vial adapter configured to receive a vial and including a vial spike, the vial spike being configured to puncture a vial stopper of the vial and defining a vial spike lumen;an intravenous (IV) port configured to receive a port spike of an infusion set; anda connector body including: a vial adapter lumen in fluid communication with the vial spike lumen, wherein the vial adapter is permanently secured to the vial adapter lumen,a barrel connected to the IV port, andan IV spike including a central wall and defining: a first IV spike lumen in fluid communication with the vial adapter lumen and having a distal-facing aperture, anda second IV spike lumen in fluid communication with the IV port and having a side-facing aperture,wherein the first IV spike lumen and the second IV spike lumen are separated by the central wall, and the central wall has a transverse protrusion forming a distal surface of the second IV spike lumen.
  • 2. The liquid transfer device of claim 1, wherein the distal-facing aperture is aligned with a longitudinal axis of the first IV spike lumen.
  • 3. The liquid transfer device of claim 1, wherein the IV spike has a tapered distal tip, and the distal-facing aperture extends through the tapered distal tip.
  • 4. The liquid transfer device of claim 1, wherein the side-facing aperture is lateral of a longitudinal axis of the second IV spike lumen.
  • 5. The liquid transfer device of claim 1, wherein the vial adapter includes a skirt configured to telescopically receive the vial, and the skirt includes at least two inwardly directed protrusions for snap-fitting under a flange of the vial.
  • 6. The liquid transfer device of claim 1, wherein the IV port includes: a connecting member having an internal lumen and a septum configured to be punctured by the port spike of the infusion set; anda twist-off member frangibly attached to the connecting member and configured to be removed from the connecting member to enable access to the septum to be punctured by the port spike of the infusion set.
  • 7. The liquid transfer device of claim 1, wherein the barrel is aligned with a longitudinal axis of the IV spike, and the vial adapter lumen is angularly disposed relative to the longitudinal axis of the IV spike.
  • 8. The liquid transfer device of claim 1, wherein the connector body has a flange extending laterally for gripping.
  • 9. A liquid transfer device comprising: a vial adapter configured to receive a vial and including a vial spike, the vial spike being configured to puncture a vial stopper of the vial and defining a vial spike lumen;an intravenous (IV) port configured to receive a port spike of an infusion set; anda connector body including: a vial adapter lumen in fluid communication with the vial spike lumen, wherein the vial adapter is permanently secured to the vial adapter lumen,a barrel connected to the IV port, andan IV spike including a central wall and defining: a first IV spike lumen in fluid communication with the vial adapter lumen and having a first aperture aligned with a longitudinal axis of the first IV spike lumen, anda second IV spike lumen in fluid communication with the IV port and having a second aperture lateral of a longitudinal axis of the second IV spike lumen,wherein the first IV spike lumen and the second IV spike lumen are separated by the central wall, and the central wall has a transverse protrusion forming a distal surface of the second IV spike lumen.
  • 10. The liquid transfer device of claim 9, wherein the first aperture is distal-facing and the second aperture is side-facing.
  • 11. The liquid transfer device of claim 9, wherein the IV spike has a tapered distal tip, and the second aperture extends through the tapered distal tip.
  • 12. The liquid transfer device of claim 9, wherein the vial adapter includes a skirt configured to telescopically receive the vial, and the skirt includes at least two inwardly directed protrusions for snap-fitting under a flange of the vial.
  • 13. The liquid transfer device of claim 9, wherein the IV port includes: a connecting member having an internal lumen and a septum configured to be punctured by the port spike of the infusion set; anda twist-off member frangibly attached to the connecting member and configured to be removed from the connecting member to enable access to the septum to be punctured by the port spike of the infusion set.
  • 14. The liquid transfer device of claim 9, wherein the barrel is aligned with a longitudinal axis of the IV spike, and the vial adapter lumen is angularly disposed relative to the longitudinal axis of the IV spike.
  • 15. The liquid transfer device of claim 9, wherein the connector body has a flange at a proximal end of the IV spike.
  • 16. A liquid transfer device comprising: a vial adapter configured to receive a vial and including a vial spike, the vial spike being configured to puncture a vial stopper of the vial and defining a vial spike lumen;an intravenous (IV) port configured to receive a port spike of an infusion set; anda connector body including: a vial adapter lumen in fluid communication with the vial spike lumen, wherein the vial adapter is permanently secured to the vial adapter lumen,a barrel connected to the IV port, andan IV spike including a central wall and defining: a first IV spike lumen being straight and in fluid communication with the vial adapter lumen, anda second IV spike lumen being L-shaped and in fluid communication with the IV port,wherein the first IV spike lumen and the second IV spike lumen are separated by the central wall, and the central wall has a transverse protrusion forming a distal surface of the second IV spike lumen.
  • 17. The liquid transfer device of claim 16, wherein the first IV spike lumen includes a distal-facing aperture aligned with a longitudinal axis of the first IV spike lumen.
  • 18. The liquid transfer device of claim 16, wherein the second IV spike lumen includes a side-facing aperture lateral of a longitudinal axis of the second IV spike lumen.
  • 19. The liquid transfer device of claim 16, wherein the vial adapter includes a skirt configured to telescopically receive the vial, and the skirt includes at least two inwardly directed protrusions for snap-fitting under a flange of the vial.
  • 20. The liquid transfer device of claim 16, wherein the IV port includes: a connecting member having an internal lumen and a septum configured to be punctured by the port spike of the infusion set; anda twist-off member frangibly attached to the connecting member and configured to be removed from the connecting member to enable access to the septum to be punctured by the port spike of the infusion set.
  • 21. The liquid transfer device of claim 16, wherein the barrel is aligned with a longitudinal axis of the IV spike, and the vial adapter lumen is angularly disposed relative to the longitudinal axis of the IV spike.
  • 22. The liquid transfer device of claim 16, wherein the connector body has a flange at a proximal end of the IV spike.
  • 23. A medicinal vial reconstitution and dispensing apparatus, comprising: a receptacle including a skirt and a vial spike configured to engage a medicinal vial, the vial spike being configured to penetrate a stopper on the medicinal vial;an intravenous (IV) connector configured for inline connection to a patient IV line; anda bifurcated body extending from the IV connector and having an IV bag spike with a tapered end, the bifurcated body enclosing a first channel and a second channel, wherein the receptacle is permanently secured to the bifurcated body,wherein the first channel is configured for fluid communication from the receptacle to an IV bag via a first orifice on the IV bag spike, the second channel is configured for transferring liquids from the IV bag to the IV connector via a second orifice on the IV bag spike, and the first orifice and the second orifice define respective fluidic connections to the receptacle and the patient IV line, and a central wall between the first channel and the second channel has a transverse protrusion forming a distal surface of the second channel.
  • 24. The apparatus of claim 23, wherein the first orifice extends through the tapered end, and the second orifice is on a side of the IV bag spike.
  • 25. The apparatus of claim 23, wherein the first orifice is aligned with a longitudinal axis of the first channel, the second orifice is aligned with a longitudinal axis of the second channel, and the first orifice is spaced distally of the second orifice.
  • 26. The apparatus of claim 23, wherein the first orifice is aligned with a longitudinal axis of the first channel, and the second orifice is lateral of a longitudinal axis of the second channel.
  • 27. The apparatus of claim 23, wherein the IV connector includes: a connecting member having an internal lumen and a septum configured to be punctured by a port spike of the patient IV line; anda twist-off member frangibly attached to the connecting member and configured to be removed from the connecting member to enable access to the septum to be punctured by the port spike of an infusion set.
  • 28. The apparatus of claim 23, wherein the bifurcated body has a flange at a proximal end of the IV bag spike.
  • 29. The liquid transfer device of claim 8, wherein the flange extends laterally of a longitudinal axis of the barrel.
  • 30. The liquid transfer device of claim 1, wherein the side-facing aperture is defined between the distal surface formed by the transverse protrusion and a proximal surface on an outer wall of the IV spike, the proximal surface being angled relative to the distal surface.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 16/982,410, filed Sep. 18, 2020, which is a Section 371 of International Appl. No. PCT/IL2020/050048, filed Jan. 13, 2020, and claims priority to and benefit from U.S. Provisional Patent Application No. 62/840,620, filed Apr. 30, 2019, the entire contents of which are incorporated by reference herein.

US Referenced Citations (964)
Number Name Date Kind
62333 Hall Feb 1867 A
247975 Wickes Oct 1881 A
254444 Vogel et al. Feb 1882 A
300060 Ford Jun 1884 A
1021681 Jennings Mar 1912 A
1704817 Ayers Mar 1929 A
1930944 Schmitz, Jr. Oct 1933 A
2326490 Perelson Aug 1943 A
2560162 Ferguson Jul 1951 A
2748769 Jennie Jun 1956 A
2830587 James Apr 1958 A
2931668 Baley Apr 1960 A
2968497 Mervyn Jan 1961 A
3059643 Barton Oct 1962 A
D198499 Andrew et al. Jun 1964 S
3225763 Waterman Dec 1965 A
3277893 Clark Oct 1966 A
3308822 De Luca Mar 1967 A
3484849 Huebner et al. Dec 1969 A
3618637 Santomieri Nov 1971 A
3757981 Harris, Sr. et al. Sep 1973 A
D229518 Bujan Dec 1973 S
3782365 Pinna Jan 1974 A
3788524 Davis et al. Jan 1974 A
3822700 Pennington Jul 1974 A
3826261 Killinger Jul 1974 A
3872992 Arson Mar 1975 A
3885607 Peltier May 1975 A
3938520 Scislowicz et al. Feb 1976 A
3957052 Topham May 1976 A
3977555 Larson Aug 1976 A
3993063 Larrabee Nov 1976 A
4020839 Klapp May 1977 A
4026128 Blanco May 1977 A
4051852 Villari Oct 1977 A
D247975 Luther May 1978 S
D248568 Ismach Jul 1978 S
4109670 Slagel Aug 1978 A
4121585 Becker, Jr. Oct 1978 A
4161178 Genese Jul 1979 A
4187848 Taylor Feb 1980 A
D254444 Levine Mar 1980 S
4203067 Bollongino et al. May 1980 A
4203443 Genese May 1980 A
4210173 Choksi et al. Jul 1980 A
D257286 Folkman Oct 1980 S
4253501 Ogle Mar 1981 A
4262671 Kersten Apr 1981 A
4296786 Brignola Oct 1981 A
4303067 Connolly et al. Dec 1981 A
4312349 Cohen Jan 1982 A
4314586 Folkman Feb 1982 A
4328802 Curley et al. May 1982 A
4335717 Bujan et al. Jun 1982 A
D267199 Koenig Dec 1982 S
4364387 Larkin Dec 1982 A
4376634 Prior et al. Mar 1983 A
D268871 Benham et al. May 1983 S
4392850 Elias et al. Jul 1983 A
D270282 Gross Aug 1983 S
4410321 Pearson et al. Oct 1983 A
4411662 Pearson Oct 1983 A
D271421 Fetterman Nov 1983 S
4434823 Hudspith Mar 1984 A
4465471 Harris et al. Aug 1984 A
4475915 Sloane Oct 1984 A
4493348 Lemmons Jan 1985 A
4505709 Froning et al. Mar 1985 A
4507113 Dunlap Mar 1985 A
D280018 Scott Aug 1985 S
4532969 Kwaan Aug 1985 A
4534758 Akers et al. Aug 1985 A
4547900 Larkin Oct 1985 A
4561445 Berke et al. Dec 1985 A
4564054 Gustavsson Jan 1986 A
4573993 Hoag et al. Mar 1986 A
4576211 Valentini et al. Mar 1986 A
4581014 Millerd et al. Apr 1986 A
4585446 Kempf Apr 1986 A
4588396 Stroebel et al. May 1986 A
4588403 Weiss et al. May 1986 A
D284603 Loignon Jul 1986 S
4604093 Brown et al. Aug 1986 A
4607671 Aalto et al. Aug 1986 A
4614437 Buehler Sep 1986 A
4638975 Iuchi et al. Jan 1987 A
4639019 Mittleman Jan 1987 A
4667927 Oscarsson May 1987 A
4675020 Mcphee Jun 1987 A
4676530 Nordgren et al. Jun 1987 A
D291490 Raines Aug 1987 S
4683975 Booth et al. Aug 1987 A
4697622 Swift et al. Oct 1987 A
4721133 Sundblom Jan 1988 A
4729401 Raines Mar 1988 A
4735608 Sardam Apr 1988 A
4743229 Chu May 1988 A
4743243 Vaillancourt May 1988 A
4752292 Lopez et al. Jun 1988 A
4758235 Tu Jul 1988 A
4759756 Forman et al. Jul 1988 A
4778447 Velde et al. Oct 1988 A
4787898 Raines Nov 1988 A
4797898 Martinez Jan 1989 A
D300060 Molgaard-Nielsen Feb 1989 S
4804366 Zdeb et al. Feb 1989 A
4826492 Magasi May 1989 A
4832690 Kuu May 1989 A
4834152 Howson et al. May 1989 A
4834744 Ritson May 1989 A
D303013 Konopka Aug 1989 S
4857062 Russell Aug 1989 A
4865592 Rycroft Sep 1989 A
4871463 Taylor et al. Oct 1989 A
4898209 Zdeb Feb 1990 A
4909290 Coccia Mar 1990 A
4919596 Slate et al. Apr 1990 A
4927423 Malmborg May 1990 A
4931040 Taber et al. Jun 1990 A
4932944 Jagger et al. Jun 1990 A
4967797 Manska Nov 1990 A
D314050 Sone Jan 1991 S
D314622 Andersson et al. Feb 1991 S
4997430 Van Der Heiden et al. Mar 1991 A
5006114 Rogers et al. Apr 1991 A
5035686 Crittenden et al. Jul 1991 A
5041105 D'Alo et al. Aug 1991 A
5045066 Scheuble et al. Sep 1991 A
5049129 Zdeb et al. Sep 1991 A
5053015 Gross Oct 1991 A
5061248 Sacco Oct 1991 A
5088996 Kopfer et al. Feb 1992 A
5096575 Cosack Mar 1992 A
5104387 Pokorney et al. Apr 1992 A
5113904 Aslanian May 1992 A
5122124 Novacek et al. Jun 1992 A
5125908 Cohen Jun 1992 A
5125915 Berry et al. Jun 1992 A
D328788 Sagae et al. Aug 1992 S
D331281 Levine Nov 1992 S
5171230 Eland et al. Dec 1992 A
5181508 Poole, Jr. Jan 1993 A
5201705 Berglund et al. Apr 1993 A
5201717 Wyatt et al. Apr 1993 A
5203771 Melker et al. Apr 1993 A
5203775 Frank et al. Apr 1993 A
5211638 Dudar et al. May 1993 A
D337828 David Jul 1993 S
5232029 Knox et al. Aug 1993 A
5232109 Tirrell et al. Aug 1993 A
5242432 Defrank Sep 1993 A
5247972 Tetreault Sep 1993 A
D341420 Conn Nov 1993 S
5269768 Cheung Dec 1993 A
5270219 Decastro et al. Dec 1993 A
5279576 Loo et al. Jan 1994 A
5288290 Brody Feb 1994 A
5300034 Behnke et al. Apr 1994 A
5301685 Guirguis Apr 1994 A
5304163 Bonnici et al. Apr 1994 A
5304165 Haber et al. Apr 1994 A
5308483 Sklar et al. May 1994 A
5312377 Dalton May 1994 A
5328474 Raines Jul 1994 A
D349648 Tirrell et al. Aug 1994 S
5334163 Sinnett Aug 1994 A
5334179 Poli et al. Aug 1994 A
5342346 Honda et al. Aug 1994 A
5344417 Wadsworth, Jr. Sep 1994 A
5348544 Sweeney et al. Sep 1994 A
5348548 Meyer et al. Sep 1994 A
5350372 Ikeda et al. Sep 1994 A
5364386 Fukuoka et al. Nov 1994 A
5364387 Sweeney Nov 1994 A
5374264 Wadsworth, Jr. Dec 1994 A
5385547 Wong et al. Jan 1995 A
5397303 Sancoff et al. Mar 1995 A
D357733 Matkovich Apr 1995 S
5429614 Fowles et al. Jul 1995 A
5433330 Yatsko et al. Jul 1995 A
5445630 Richmond Aug 1995 A
5445631 Uchida Aug 1995 A
D362718 Deily et al. Sep 1995 S
5451374 Molina Sep 1995 A
5454805 Brony Oct 1995 A
5464111 Vacek et al. Nov 1995 A
5464123 Scarrow Nov 1995 A
5466219 Lynn et al. Nov 1995 A
5466220 Brenneman Nov 1995 A
5470327 Helgren et al. Nov 1995 A
5471994 Guirguis Dec 1995 A
5472022 Michel et al. Dec 1995 A
5478337 Okamoto et al. Dec 1995 A
5482446 Williamson et al. Jan 1996 A
5492147 Challender et al. Feb 1996 A
5496274 Graves et al. Mar 1996 A
D369406 Niedospial et al. Apr 1996 S
5505714 Dassa et al. Apr 1996 A
5509433 Paradis Apr 1996 A
5515871 Bittner et al. May 1996 A
5520659 Tedges May 1996 A
5526853 Mcphee et al. Jun 1996 A
5527306 Haining Jun 1996 A
5531695 Swisher Jul 1996 A
5547471 Thompson et al. Aug 1996 A
5549577 Siegel et al. Aug 1996 A
5554128 Hedges Sep 1996 A
5562686 Sauer et al. Oct 1996 A
5562696 Nobles et al. Oct 1996 A
5566729 Grabenkort et al. Oct 1996 A
5569191 Meyer Oct 1996 A
5573281 Keller Nov 1996 A
5578015 Robb Nov 1996 A
5583052 Portnoff et al. Dec 1996 A
5584819 Kopfer Dec 1996 A
5591143 Trombley et al. Jan 1997 A
5603706 Wyatt et al. Feb 1997 A
5607439 Yoon Mar 1997 A
5611576 Guala Mar 1997 A
5616203 Stevens Apr 1997 A
5636660 Pfleiderer et al. Jun 1997 A
5637101 Shillington Jun 1997 A
5641010 Maier Jun 1997 A
5645538 Richmond Jul 1997 A
5647845 Haber et al. Jul 1997 A
5651776 Appling et al. Jul 1997 A
5653686 Coulter et al. Aug 1997 A
5658133 Anderson et al. Aug 1997 A
5672160 Osterlind et al. Sep 1997 A
5674195 Truthan Oct 1997 A
5676346 Leinsing Oct 1997 A
5685845 Grimard Nov 1997 A
D388172 Cipes Dec 1997 S
5699821 Paradis Dec 1997 A
5702019 Grimard Dec 1997 A
5718346 Weiler Feb 1998 A
5728087 Niedospial, Jr. Mar 1998 A
D393722 Fangrow et al. Apr 1998 S
5738144 Rogers Apr 1998 A
5743312 Pfeifer et al. Apr 1998 A
5746733 Capaccio et al. May 1998 A
5752942 Doyle et al. May 1998 A
5755696 Caizza May 1998 A
5766211 Wood et al. Jun 1998 A
5772630 Ljungquist Jun 1998 A
5772652 Zielinski Jun 1998 A
RE35841 Frank et al. Jul 1998 E
5776116 Lopez et al. Jul 1998 A
5782872 Mueller Jul 1998 A
5806831 Paradis Sep 1998 A
5810792 Fangrow et al. Sep 1998 A
5814020 Gross Sep 1998 A
D399558 Guala et al. Oct 1998 S
D399559 Molina Oct 1998 S
5817082 Niedospial et al. Oct 1998 A
5820621 Yale et al. Oct 1998 A
5827262 Neftel et al. Oct 1998 A
5832971 Yale et al. Nov 1998 A
5833213 Ryan Nov 1998 A
5834744 Risman Nov 1998 A
5839715 Leinsing Nov 1998 A
D403398 Guala et al. Dec 1998 S
5853406 Masuda et al. Dec 1998 A
D405522 Hoenig et al. Feb 1999 S
5868710 Battiato et al. Feb 1999 A
5871110 Grimard et al. Feb 1999 A
5873872 Thibault et al. Feb 1999 A
5879337 Kuracina et al. Mar 1999 A
5879345 Aneas Mar 1999 A
5887633 Yale et al. Mar 1999 A
5890610 Jansen et al. Apr 1999 A
5891129 Daubert et al. Apr 1999 A
5893397 Peterson et al. Apr 1999 A
5897526 Vaillancourt Apr 1999 A
5899468 Apps et al. May 1999 A
5902280 Powles et al. May 1999 A
5902298 Niedospial et al. May 1999 A
D410740 Molina Jun 1999 S
5911710 Barry et al. Jun 1999 A
5919182 Avallone Jul 1999 A
5921419 Niedospial et al. Jul 1999 A
5924584 Hellstrom et al. Jul 1999 A
5925029 Jansen et al. Jul 1999 A
5935112 Stevens et al. Aug 1999 A
5941848 Nishimoto et al. Aug 1999 A
5941850 Shah et al. Aug 1999 A
5944700 Nguyen et al. Aug 1999 A
D414562 Tajima Sep 1999 S
5954104 Daubert et al. Sep 1999 A
5968022 Saito Oct 1999 A
5971181 Niedospial et al. Oct 1999 A
5971965 Mayer Oct 1999 A
D416086 Parris et al. Nov 1999 S
5989237 Fowles et al. Nov 1999 A
D417733 Howell et al. Dec 1999 S
6003566 Thibault et al. Dec 1999 A
6004278 Botich et al. Dec 1999 A
6019750 Fowles et al. Feb 2000 A
6022339 Fowles et al. Feb 2000 A
6036171 Weinheimer et al. Mar 2000 A
6039093 Mrotzek et al. Mar 2000 A
6039302 Cote et al. Mar 2000 A
D422357 Niedospial et al. Apr 2000 S
6053899 Slanda et al. Apr 2000 A
6063068 Fowles et al. May 2000 A
D427308 Zinger Jun 2000 S
D427309 Molina Jun 2000 S
6070623 Aneas Jun 2000 A
6071270 Fowles et al. Jun 2000 A
6080132 Cole et al. Jun 2000 A
D428141 Brotspies et al. Jul 2000 S
6086762 Guala Jul 2000 A
6089541 Weinheimer et al. Jul 2000 A
6090091 Fowles et al. Jul 2000 A
6090093 Thibault et al. Jul 2000 A
6092692 Riskin Jul 2000 A
D430291 Jansen et al. Aug 2000 S
6099511 Devos et al. Aug 2000 A
6113068 Ryan Sep 2000 A
6113583 Fowles et al. Sep 2000 A
6117114 Paradis Sep 2000 A
D431864 Jansen Oct 2000 S
6139534 Niedospial et al. Oct 2000 A
6142446 Leinsing Nov 2000 A
6146362 Turnbull et al. Nov 2000 A
6149623 Reynolds Nov 2000 A
6156025 Niedospial et al. Dec 2000 A
6159192 Fowles et al. Dec 2000 A
6162199 Geringer Dec 2000 A
6168037 Grimard Jan 2001 B1
6171287 Lynn et al. Jan 2001 B1
6171293 Rowley et al. Jan 2001 B1
6173852 Browne Jan 2001 B1
6173868 Dejonge Jan 2001 B1
6174304 Weston Jan 2001 B1
6179822 Niedospial, Jr. Jan 2001 B1
6179823 Niedospial, Jr. Jan 2001 B1
6186997 Gabbard et al. Feb 2001 B1
6206861 Mayer Mar 2001 B1
6221041 Russo Apr 2001 B1
6221054 Martin et al. Apr 2001 B1
6221065 Davis Apr 2001 B1
6238372 Zinger et al. May 2001 B1
6245044 Daw et al. Jun 2001 B1
D445501 Niedospial Jul 2001 S
D445895 Svendsen Jul 2001 S
6253804 Safabash Jul 2001 B1
6258078 Thilly Jul 2001 B1
6280430 Neftel et al. Aug 2001 B1
6290688 Lopez et al. Sep 2001 B1
6296621 Masuda et al. Oct 2001 B1
6299131 Ryan Oct 2001 B1
D453221 Haytman et al. Jan 2002 S
6343629 Wessman et al. Feb 2002 B1
6348044 Coletti et al. Feb 2002 B1
6358236 Defoggi et al. Mar 2002 B1
6364866 Furr et al. Apr 2002 B1
6378576 Thibault et al. Apr 2002 B2
6378714 Jansen et al. Apr 2002 B1
6379340 Zinger et al. Apr 2002 B1
D457954 Wallace et al. May 2002 S
6382442 Thibault et al. May 2002 B1
6386397 Brotspies et al. May 2002 B2
6408897 Laurent et al. Jun 2002 B1
6409708 Wessman Jun 2002 B1
6419696 Ortiz et al. Jul 2002 B1
6440107 Trombley et al. Aug 2002 B1
6453949 Chau Sep 2002 B1
6453956 Safabash Sep 2002 B2
6474375 Spero et al. Nov 2002 B2
6478788 Aneas Nov 2002 B1
D468015 Horppu Dec 2002 S
6499617 Niedospial et al. Dec 2002 B1
6503240 Niedospial et al. Jan 2003 B1
6503244 Hayman Jan 2003 B2
6520932 Taylor Feb 2003 B2
6524278 Campbell et al. Feb 2003 B1
6524295 Daubert et al. Feb 2003 B2
D472316 Douglas et al. Mar 2003 S
6530903 Wang et al. Mar 2003 B2
6537263 Aneas Mar 2003 B1
D472630 Douglas et al. Apr 2003 S
6544246 Niedospial Apr 2003 B1
6551299 Miyoshi et al. Apr 2003 B2
6558365 Zinger et al. May 2003 B2
6569196 Vesely May 2003 B1
6571837 Jansen et al. Jun 2003 B2
6572591 Mayer Jun 2003 B2
6575955 Azzolini Jun 2003 B2
6581593 Rubin et al. Jun 2003 B1
6581648 Zolentroff et al. Jun 2003 B1
6582415 Fowles et al. Jun 2003 B1
D476731 Cise et al. Jul 2003 S
6591876 Safabash Jul 2003 B2
6599273 Lopez Jul 2003 B1
6601721 Jansen et al. Aug 2003 B2
6626309 Jansen et al. Sep 2003 B1
6632201 Mathias et al. Oct 2003 B1
6638244 Reynolds Oct 2003 B1
D482121 Harding et al. Nov 2003 S
D482447 Harding et al. Nov 2003 S
6651956 Miller Nov 2003 B2
6652509 Helgren et al. Nov 2003 B1
D483487 Harding et al. Dec 2003 S
D483869 Tran et al. Dec 2003 S
6656433 Sasso Dec 2003 B2
6666852 Niedospial Dec 2003 B2
6681810 Weston Jan 2004 B2
6681946 Jansen et al. Jan 2004 B1
6682509 Lopez Jan 2004 B2
6692478 Paradis Feb 2004 B1
6692829 Stubler et al. Feb 2004 B2
6695829 Hellstrom et al. Feb 2004 B2
6699229 Zinger et al. Mar 2004 B2
6699232 Hart et al. Mar 2004 B2
6706022 Leinsing et al. Mar 2004 B1
6706031 Manera Mar 2004 B2
6715520 Andreasson et al. Apr 2004 B2
6729370 Norton et al. May 2004 B2
6736798 Ohkubo et al. May 2004 B2
6745998 Doyle Jun 2004 B2
6746438 Arnissolle Jun 2004 B1
6752180 Delay Jun 2004 B2
D495416 Dimeo et al. Aug 2004 S
D496457 Prais et al. Sep 2004 S
6802490 Leinsing et al. Oct 2004 B2
6832994 Niedospial et al. Dec 2004 B2
6852103 Fowles et al. Feb 2005 B2
6875203 Fowles et al. Apr 2005 B1
6875205 Leinsing Apr 2005 B2
6878131 Novacek et al. Apr 2005 B2
6884253 Mcfarlane Apr 2005 B1
6890328 Fowles et al. May 2005 B2
D506256 Miyoshi et al. Jun 2005 S
6901975 Aramata et al. Jun 2005 B2
6945417 Jansen et al. Sep 2005 B2
6948522 Newbrough et al. Sep 2005 B2
6949086 Ferguson et al. Sep 2005 B2
6951613 Reif et al. Oct 2005 B2
6953450 Baldwin et al. Oct 2005 B2
6957745 Thibault et al. Oct 2005 B2
6960164 O'Heeron Nov 2005 B2
6964684 Ortiz et al. Nov 2005 B2
6972002 Thorne Dec 2005 B2
6979318 Mcdonald et al. Dec 2005 B1
RE38996 Crawford et al. Feb 2006 E
6994315 Ryan et al. Feb 2006 B2
6997916 Simas et al. Feb 2006 B2
6997917 Niedospial et al. Feb 2006 B2
7024968 Raudabough et al. Apr 2006 B2
7070589 Lolachi et al. Jul 2006 B2
7074216 Fowles et al. Jul 2006 B2
7083600 Meloul Aug 2006 B2
7086431 D'Antonio et al. Aug 2006 B2
7097637 Triplett et al. Aug 2006 B2
7100890 Cote et al. Sep 2006 B2
7140401 Wilcox et al. Nov 2006 B2
7150735 Hickle Dec 2006 B2
7192423 Wong Mar 2007 B2
7195623 Burroughs et al. Mar 2007 B2
D546450 Wolf Jul 2007 S
7241285 Dikeman Jul 2007 B1
7294122 Kubo et al. Nov 2007 B2
7306199 Leinsing et al. Dec 2007 B2
D560815 Tajima Jan 2008 S
D561348 Zinger et al. Feb 2008 S
7326188 Russell et al. Feb 2008 B1
7326194 Zinger et al. Feb 2008 B2
7335213 Hyde et al. Feb 2008 B1
7350764 Raybuck Apr 2008 B2
7354422 Riesenberger et al. Apr 2008 B2
7354427 Fangrow Apr 2008 B2
D573250 Macrae et al. Jul 2008 S
D575314 Hind Aug 2008 S
7425209 Fowles et al. Sep 2008 B2
7435246 Zihlmann Oct 2008 B2
D580558 Shigesada et al. Nov 2008 S
D581529 Moehle et al. Nov 2008 S
7452348 Hasegawa Nov 2008 B2
7470257 Norton et al. Dec 2008 B2
7470265 Brugger et al. Dec 2008 B2
7472932 Weber et al. Jan 2009 B2
7488297 Flaherty Feb 2009 B2
7491197 Jansen et al. Feb 2009 B2
7497848 Leinsing et al. Mar 2009 B2
7500961 Nemoto Mar 2009 B2
7523967 Steppe Apr 2009 B2
7530546 Ryan et al. May 2009 B2
D595420 Suzuki et al. Jun 2009 S
D595421 Suzuki et al. Jun 2009 S
7540863 Haindl Jun 2009 B2
7540865 Griffin et al. Jun 2009 B2
7544191 Peluso et al. Jun 2009 B2
D595862 Suzuki et al. Jul 2009 S
D595863 Suzuki et al. Jul 2009 S
7569062 Kuehn et al. Aug 2009 B1
D604837 Crawford et al. Nov 2009 S
7611487 Woehr et al. Nov 2009 B2
7611502 Daly Nov 2009 B2
7615041 Sullivan et al. Nov 2009 B2
7628779 Aneas Dec 2009 B2
7632261 Zinger et al. Dec 2009 B2
D608900 Giraud et al. Jan 2010 S
D609804 Uchida et al. Feb 2010 S
7654995 Warren et al. Feb 2010 B2
7670326 Shemesh Mar 2010 B2
7695445 Yuki Apr 2010 B2
7703483 Hartman et al. Apr 2010 B2
7704229 Moberg et al. Apr 2010 B2
7704236 Denolly Apr 2010 B2
D616090 Kawamura May 2010 S
7713247 Lopez May 2010 B2
7717886 Lopez May 2010 B2
7722090 Burton et al. May 2010 B2
D616984 Gilboa Jun 2010 S
7731678 Tennican et al. Jun 2010 B2
7743799 Mosler et al. Jun 2010 B2
7744581 Wallen et al. Jun 2010 B2
7757901 Welp Jul 2010 B2
7758082 Weigel et al. Jul 2010 B2
7758560 Connell et al. Jul 2010 B2
7762524 Cawthon et al. Jul 2010 B2
7766304 Phillips Aug 2010 B2
7771383 Truitt et al. Aug 2010 B2
D624641 Boclet Sep 2010 S
7799009 Niedospial et al. Sep 2010 B2
7803140 Fangrow, Jr. Sep 2010 B2
D627216 Fulginiti Nov 2010 S
D630732 Lev et al. Jan 2011 S
7862537 Zinger et al. Jan 2011 B2
7867215 Akerlund et al. Jan 2011 B2
7879018 Zinger et al. Feb 2011 B2
7883499 Fangrow Feb 2011 B2
7887583 Macoviak Feb 2011 B2
7895216 Longshaw et al. Feb 2011 B2
D634007 Zinger et al. Mar 2011 S
7896849 Delay Mar 2011 B2
7900659 Whitley et al. Mar 2011 B2
7914499 Gonnelli et al. Mar 2011 B2
D637713 Nord et al. May 2011 S
7963954 Kavazov Jun 2011 B2
D641080 Zinger et al. Jul 2011 S
7985216 Daily et al. Jul 2011 B2
D644104 Maeda et al. Aug 2011 S
7993328 Whitley Aug 2011 B2
8007461 Huo et al. Aug 2011 B2
8012132 Lum et al. Sep 2011 B2
8016809 Zinger et al. Sep 2011 B2
8021325 Zinger et al. Sep 2011 B2
8025653 Capitaine et al. Sep 2011 B2
8025683 Morrison Sep 2011 B2
8029472 Leinsing et al. Oct 2011 B2
8038123 Ruschke et al. Oct 2011 B2
8066688 Zinger et al. Nov 2011 B2
8070739 Zinger et al. Dec 2011 B2
8075550 Nord et al. Dec 2011 B2
8096525 Ryan Jan 2012 B2
8105314 Fangrow, Jr. Jan 2012 B2
D654166 Lair Feb 2012 S
D655017 Mosler et al. Feb 2012 S
8122923 Kraus et al. Feb 2012 B2
8123736 Kraushaar et al. Feb 2012 B2
D655071 Davila Mar 2012 S
D657461 Schembre et al. Apr 2012 S
8152779 Cabiri Apr 2012 B2
8157784 Rogers Apr 2012 B2
8167863 Yow May 2012 B2
8172824 Pfeifer et al. May 2012 B2
8177768 Leinsing May 2012 B2
8182452 Mansour et al. May 2012 B2
8187248 Zihlmann May 2012 B2
8196614 Kriheli Jun 2012 B2
8197459 Jansen et al. Jun 2012 B2
8211069 Fangrow, Jr. Jul 2012 B2
8211082 Hasegawa Jul 2012 B2
8225959 Lambrecht Jul 2012 B2
8241268 Whitley Aug 2012 B2
8262628 Fangrow, Jr. Sep 2012 B2
8262641 Vedrine et al. Sep 2012 B2
8267127 Kriheli Sep 2012 B2
D669980 Lev et al. Oct 2012 S
8287513 Ellstrom et al. Oct 2012 B2
D671654 Akamatsu et al. Nov 2012 S
8317741 Kraushaar Nov 2012 B2
8328784 Jensen et al. Dec 2012 B2
D673673 Wang Jan 2013 S
D674084 Linnenschmidt Jan 2013 S
D674088 Lev et al. Jan 2013 S
8348898 Cabiri Jan 2013 B2
D681230 Mosler et al. Apr 2013 S
8418690 Power et al. Apr 2013 B2
8454573 Wyatt et al. Jun 2013 B2
8469939 Fangrow, Jr. Jun 2013 B2
8475404 Foshee et al. Jul 2013 B2
8480645 Choudhury et al. Jul 2013 B1
8480646 Nord et al. Jul 2013 B2
8506548 Okiyama Aug 2013 B2
8511352 Kraus et al. Aug 2013 B2
8512309 Shemesh et al. Aug 2013 B2
D689605 Bellenoit Sep 2013 S
D690009 Schembre et al. Sep 2013 S
D690418 Rosenquist Sep 2013 S
8523837 Wiggins et al. Sep 2013 B2
D691264 Dallemagne et al. Oct 2013 S
8545476 Ariagno et al. Oct 2013 B2
8551067 Zinger et al. Oct 2013 B2
8556879 Okiyama Oct 2013 B2
8562582 Tuckwell et al. Oct 2013 B2
8608723 Lev et al. Dec 2013 B2
8628508 Weitzel et al. Jan 2014 B2
8636689 Halili et al. Jan 2014 B2
D703812 Cederschiold et al. Apr 2014 S
8684992 Sullivan et al. Apr 2014 B2
8684994 Lev et al. Apr 2014 B2
8752598 Denenburg et al. Jun 2014 B2
D714935 Nishioka et al. Oct 2014 S
D717406 Stanley et al. Nov 2014 S
D717948 Strong et al. Nov 2014 S
D719650 Arinobe et al. Dec 2014 S
D720067 Rosenquist Dec 2014 S
D720451 Denenburg et al. Dec 2014 S
D720452 Jordan Dec 2014 S
8900212 Kubo Dec 2014 B2
8905994 Lev et al. Dec 2014 B1
8915882 Cabiri Dec 2014 B2
D720850 Hsia et al. Jan 2015 S
8986370 Annest Mar 2015 B2
9011522 Annest Apr 2015 B2
D732660 Ohashi Jun 2015 S
D732664 Woehr et al. Jun 2015 S
D733291 Wang Jun 2015 S
D733292 Rogers Jun 2015 S
D733293 Rogers Jun 2015 S
9072827 Cabiri Jul 2015 B2
D738494 Kashmirian Sep 2015 S
D741457 Guest Oct 2015 S
9149575 Cabiri Oct 2015 B2
D750235 Maurice Feb 2016 S
9254242 Mueller et al. Feb 2016 B2
D757933 Lev et al. May 2016 S
9393365 Cabiri Jul 2016 B2
D765837 Lev et al. Sep 2016 S
D767124 Lev et al. Sep 2016 S
9486391 Shemesh Nov 2016 B2
9492610 Cabiri Nov 2016 B2
9511190 Cabiri Dec 2016 B2
9522234 Cabiri Dec 2016 B2
D794183 Lev et al. Aug 2017 S
9763855 Fangrow Sep 2017 B2
D833599 Nilsson et al. Nov 2018 S
D836324 Michalski Dec 2018 S
10206854 Wu et al. Feb 2019 B2
D849936 Allard May 2019 S
D851240 Baid Jun 2019 S
10413662 Yeh et al. Sep 2019 B2
D881389 Wang et al. Apr 2020 S
D881390 Wang et al. Apr 2020 S
10772798 Lev et al. Sep 2020 B2
D903836 Pak et al. Dec 2020 S
D923782 Lev et al. Jun 2021 S
D923812 Ben Jun 2021 S
20010000347 Hellstrom et al. Apr 2001 A1
20010025671 Safabash Oct 2001 A1
20010029360 Miyoshi et al. Oct 2001 A1
20010047150 Chobotov Nov 2001 A1
20010051793 Weston Dec 2001 A1
20020017328 Loo Feb 2002 A1
20020029080 Mortier et al. Mar 2002 A1
20020055711 Lavi et al. May 2002 A1
20020065488 Suzuki et al. May 2002 A1
20020066715 Niedospial Jun 2002 A1
20020087118 Reynolds et al. Jul 2002 A1
20020087141 Zinger et al. Jul 2002 A1
20020087144 Zinger et al. Jul 2002 A1
20020104584 Spero et al. Aug 2002 A1
20020115980 Niedospial et al. Aug 2002 A1
20020121496 Thiebault et al. Sep 2002 A1
20020123736 Fowles et al. Sep 2002 A1
20020123737 Hart et al. Sep 2002 A1
20020127150 Sasso Sep 2002 A1
20020128628 Fathallah Sep 2002 A1
20020138045 Moen Sep 2002 A1
20020173752 Polzin Nov 2002 A1
20020193777 Aneas Dec 2002 A1
20030028156 Juliar Feb 2003 A1
20030036725 Lavi et al. Feb 2003 A1
20030068354 Reif et al. Apr 2003 A1
20030069550 Sharp Apr 2003 A1
20030073971 Saker Apr 2003 A1
20030083742 Spence et al. May 2003 A1
20030100866 Reynolds May 2003 A1
20030109846 Zinger et al. Jun 2003 A1
20030120209 Jensen et al. Jun 2003 A1
20030135159 Daily et al. Jul 2003 A1
20030153895 Leinsing Aug 2003 A1
20030187420 Akerlund et al. Oct 2003 A1
20030191445 Wallen et al. Oct 2003 A1
20030195479 Kuracina et al. Oct 2003 A1
20030199827 Thorne Oct 2003 A1
20030199846 Fowles et al. Oct 2003 A1
20030199847 Akerlund et al. Oct 2003 A1
20030205843 Adams Nov 2003 A1
20030236543 Brenneman et al. Dec 2003 A1
20040010207 Flaherty et al. Jan 2004 A1
20040024354 Reynolds Feb 2004 A1
20040039365 Aramata et al. Feb 2004 A1
20040044327 Hasegawa Mar 2004 A1
20040044406 Woolfson et al. Mar 2004 A1
20040073189 Wyatt et al. Apr 2004 A1
20040143218 Das Jul 2004 A1
20040143226 Marsden Jul 2004 A1
20040153047 Blank et al. Aug 2004 A1
20040158172 Hancock Aug 2004 A1
20040162515 Chornenky et al. Aug 2004 A1
20040162540 Walenciak et al. Aug 2004 A1
20040167472 Howell et al. Aug 2004 A1
20040167620 Ortiz et al. Aug 2004 A1
20040181192 Cuppy Sep 2004 A1
20040186424 Hjertman Sep 2004 A1
20040199139 Fowles et al. Oct 2004 A1
20040204699 Hanly et al. Oct 2004 A1
20040217315 Doyle Nov 2004 A1
20040225274 Jansen et al. Nov 2004 A1
20040236305 Jansen et al. Nov 2004 A1
20040236419 Milo Nov 2004 A1
20040249341 Newbrough et al. Dec 2004 A1
20040255952 Carlsen et al. Dec 2004 A1
20050010287 Macoviak et al. Jan 2005 A1
20050015070 Delnevo et al. Jan 2005 A1
20050016626 Wilcox et al. Jan 2005 A1
20050049553 Triplett et al. Mar 2005 A1
20050055008 Paradis et al. Mar 2005 A1
20050070999 Spence Mar 2005 A1
20050075727 Wheatley Apr 2005 A1
20050082828 Wicks et al. Apr 2005 A1
20050124964 Niedospial et al. Jun 2005 A1
20050137523 Wyatt et al. Jun 2005 A1
20050137566 Fowles et al. Jun 2005 A1
20050137702 Haug et al. Jun 2005 A1
20050148994 Leinsing Jul 2005 A1
20050159706 Wilkinson et al. Jul 2005 A1
20050159724 Enerson Jul 2005 A1
20050182383 Wallen Aug 2005 A1
20050209554 Landau Sep 2005 A1
20050261637 Miller Nov 2005 A1
20050277896 Messerli et al. Dec 2005 A1
20060030832 Niedospial et al. Feb 2006 A1
20060049209 Baker Mar 2006 A1
20060058741 Gallagher Mar 2006 A1
20060074484 Huber Apr 2006 A1
20060079834 Tennican et al. Apr 2006 A1
20060089594 Landau Apr 2006 A1
20060089603 Truitt et al. Apr 2006 A1
20060095015 Hobbs et al. May 2006 A1
20060106360 Wong May 2006 A1
20060135948 Varma Jun 2006 A1
20060155257 Reynolds Jul 2006 A1
20060161192 Young Jul 2006 A1
20060169348 Yigal Aug 2006 A1
20060173410 Moberg et al. Aug 2006 A1
20060178646 Harris et al. Aug 2006 A1
20060195029 Shults et al. Aug 2006 A1
20060212004 Atil Sep 2006 A1
20060224105 Thorne et al. Oct 2006 A1
20060253084 Nordgren Nov 2006 A1
20060259004 Connell et al. Nov 2006 A1
20060259135 Navia et al. Nov 2006 A1
20070016381 Kamath et al. Jan 2007 A1
20070024995 Hayashi Feb 2007 A1
20070060904 Vedrine et al. Mar 2007 A1
20070078428 Reynolds et al. Apr 2007 A1
20070079894 Kraus et al. Apr 2007 A1
20070083164 Barrelle et al. Apr 2007 A1
20070088252 Pestotnik et al. Apr 2007 A1
20070088293 Fangrow Apr 2007 A1
20070088313 Zinger et al. Apr 2007 A1
20070095856 Vogel et al. May 2007 A1
20070106218 Yodfat et al. May 2007 A1
20070106244 Mosler et al. May 2007 A1
20070112324 Hamedi-Sangsari May 2007 A1
20070156112 Walsh Jul 2007 A1
20070167904 Zinger et al. Jul 2007 A1
20070167912 Causey et al. Jul 2007 A1
20070191760 Iguchi et al. Aug 2007 A1
20070191764 Zihlmann Aug 2007 A1
20070191767 Hennessy et al. Aug 2007 A1
20070203451 Murakami et al. Aug 2007 A1
20070219483 Kitani et al. Sep 2007 A1
20070244447 Capitaine et al. Oct 2007 A1
20070244461 Fangrow Oct 2007 A1
20070244462 Fangrow Oct 2007 A1
20070244463 Warren et al. Oct 2007 A1
20070249995 Van Oct 2007 A1
20070255202 Kitani et al. Nov 2007 A1
20070265574 Tennican et al. Nov 2007 A1
20070265581 Funamura et al. Nov 2007 A1
20070270778 Zinger et al. Nov 2007 A9
20070287953 Ziv et al. Dec 2007 A1
20070299404 Katoh et al. Dec 2007 A1
20080009789 Zinger et al. Jan 2008 A1
20080009822 Enerson Jan 2008 A1
20080015496 Hamedi-Sangsari Jan 2008 A1
20080039935 Buch et al. Feb 2008 A1
20080077235 Kirson Mar 2008 A1
20080125860 Webler et al. May 2008 A1
20080135051 Lee Jun 2008 A1
20080167713 Bolling Jul 2008 A1
20080172024 Yow Jul 2008 A1
20080188799 Mueller-Beckhaus et al. Aug 2008 A1
20080195049 Thalmann et al. Aug 2008 A1
20080208138 Lim et al. Aug 2008 A1
20080215015 Cindrich et al. Sep 2008 A1
20080249473 Rutti et al. Oct 2008 A1
20080249479 Zinger et al. Oct 2008 A1
20080249498 Fangrow Oct 2008 A1
20080262465 Zinger Oct 2008 A1
20080262609 Gross et al. Oct 2008 A1
20080269687 Chong et al. Oct 2008 A1
20080275407 Scheurer Nov 2008 A1
20080287905 Hiejima et al. Nov 2008 A1
20080294100 De et al. Nov 2008 A1
20080306439 Nelson et al. Dec 2008 A1
20080312634 Helmerson et al. Dec 2008 A1
20090012492 Zihlmann Jan 2009 A1
20090043253 Podaima Feb 2009 A1
20090054834 Zinger et al. Feb 2009 A1
20090054852 Takano et al. Feb 2009 A1
20090054969 Salahieh et al. Feb 2009 A1
20090062767 Van et al. Mar 2009 A1
20090076360 Brister et al. Mar 2009 A1
20090082750 Denenburg et al. Mar 2009 A1
20090139724 Gray et al. Jun 2009 A1
20090143758 Okiyama Jun 2009 A1
20090177177 Zinger et al. Jul 2009 A1
20090177178 Pedersen Jul 2009 A1
20090187140 Racz Jul 2009 A1
20090216103 Brister et al. Aug 2009 A1
20090216212 Fangrow, Jr. Aug 2009 A1
20090257306 Coffeen et al. Oct 2009 A1
20090267011 Hatton et al. Oct 2009 A1
20090299325 Vedrine et al. Dec 2009 A1
20090318946 Tamesada Dec 2009 A1
20090326506 Hasegawa et al. Dec 2009 A1
20100010443 Morgan et al. Jan 2010 A1
20100016811 Smith Jan 2010 A1
20100022985 Sullivan et al. Jan 2010 A1
20100030181 Helle et al. Feb 2010 A1
20100036319 Drake et al. Feb 2010 A1
20100042147 Panovsky et al. Feb 2010 A1
20100049315 Kirson Feb 2010 A1
20100070027 Bonhoeffer et al. Mar 2010 A1
20100076397 Reed et al. Mar 2010 A1
20100087786 Zinger et al. Apr 2010 A1
20100137827 Warren et al. Jun 2010 A1
20100137831 Tsals Jun 2010 A1
20100152658 Hanson et al. Jun 2010 A1
20100160889 Smith et al. Jun 2010 A1
20100161047 Cabiri Jun 2010 A1
20100162548 Leidig Jul 2010 A1
20100168664 Zinger et al. Jul 2010 A1
20100168712 Tuckwell et al. Jul 2010 A1
20100179506 Shemesh et al. Jul 2010 A1
20100198148 Zinger et al. Aug 2010 A1
20100204670 Kraushaar et al. Aug 2010 A1
20100228220 Zinger et al. Sep 2010 A1
20100241088 Ranalletta et al. Sep 2010 A1
20100262232 Annest Oct 2010 A1
20100274184 Chun Oct 2010 A1
20100274202 Tyde et al. Oct 2010 A1
20100286661 Raday et al. Nov 2010 A1
20100305548 Kraushaar Dec 2010 A1
20100312220 Kalitzki Dec 2010 A1
20110004143 Beiriger et al. Jan 2011 A1
20110004184 Proksch et al. Jan 2011 A1
20110044850 Solomon et al. Feb 2011 A1
20110054440 Lewis Mar 2011 A1
20110087164 Mosler et al. Apr 2011 A1
20110125056 Merchant May 2011 A1
20110144584 Wozencroft Jun 2011 A1
20110160655 Hanson et al. Jun 2011 A1
20110160701 Wyatt et al. Jun 2011 A1
20110172636 Aasmul Jul 2011 A1
20110175347 Okiyama Jul 2011 A1
20110178493 Okiyama Jul 2011 A1
20110218511 Yokoyama Sep 2011 A1
20110224640 Kuehn et al. Sep 2011 A1
20110230856 Kyle et al. Sep 2011 A1
20110264037 Foshee et al. Oct 2011 A1
20110264069 Bochenko Oct 2011 A1
20110275988 Davis et al. Nov 2011 A1
20110276007 Denenburg Nov 2011 A1
20110319827 Leinsing et al. Dec 2011 A1
20120022344 Kube Jan 2012 A1
20120022469 Alpert Jan 2012 A1
20120053555 Ariagno et al. Mar 2012 A1
20120059332 Woehr et al. Mar 2012 A1
20120059346 Sheppard et al. Mar 2012 A1
20120067429 Mosler et al. Mar 2012 A1
20120071819 Brueggemann et al. Mar 2012 A1
20120078214 Finke et al. Mar 2012 A1
20120123382 Kubo May 2012 A1
20120184938 Lev et al. Jul 2012 A1
20120215182 Mansour et al. Aug 2012 A1
20120220977 Yow Aug 2012 A1
20120220978 Lev et al. Aug 2012 A1
20120265163 Cheng et al. Oct 2012 A1
20120271229 Lev et al. Oct 2012 A1
20120296307 Holt et al. Nov 2012 A1
20120310203 Khaled et al. Dec 2012 A1
20120323172 Lev et al. Dec 2012 A1
20120323187 Iwase et al. Dec 2012 A1
20120323210 Lev et al. Dec 2012 A1
20130046269 Lev et al. Feb 2013 A1
20130053814 Mueller-Beckhaus et al. Feb 2013 A1
20130096493 Kubo et al. Apr 2013 A1
20130110049 Cronenberg et al. May 2013 A1
20130144248 Putter et al. Jun 2013 A1
20130199669 Moy et al. Aug 2013 A1
20130226100 Lev Aug 2013 A1
20130231630 Kraus et al. Sep 2013 A1
20130237904 Deneburg et al. Sep 2013 A1
20130253448 Baron et al. Sep 2013 A1
20130289530 Wyatt et al. Oct 2013 A1
20130315026 Cheio et al. Nov 2013 A1
20130317472 Finke Nov 2013 A1
20140020793 Denenburg et al. Jan 2014 A1
20140096862 Aneas Apr 2014 A1
20140102552 Shemesh Apr 2014 A1
20140150911 Hanner et al. Jun 2014 A1
20140194854 Tsals Jul 2014 A1
20140221940 Clauson et al. Aug 2014 A1
20140276215 Nelson et al. Sep 2014 A1
20140277052 Haselby et al. Sep 2014 A1
20140352845 Lev et al. Dec 2014 A1
20150082746 Ivosevic et al. Mar 2015 A1
20150088078 Lev et al. Mar 2015 A1
20150112297 Lev et al. Apr 2015 A1
20150209230 Lev et al. Jul 2015 A1
20150250681 Lev et al. Sep 2015 A1
20150290390 Ring et al. Oct 2015 A1
20150297839 Sanders et al. Oct 2015 A1
20150297880 Ogawa et al. Oct 2015 A1
20150305770 Fill et al. Oct 2015 A1
20160081308 Cary et al. Mar 2016 A1
20160081878 Marks et al. Mar 2016 A1
20160088995 Ueda et al. Mar 2016 A1
20160166824 Lev et al. Jun 2016 A1
20160199569 Yevmenenko et al. Jul 2016 A1
20160228644 Cabiri Aug 2016 A1
20160287475 Yevmenenko et al. Oct 2016 A1
20160367439 Davis et al. Dec 2016 A1
20180008513 Iibuchi et al. Jan 2018 A1
20180161243 Ariagno et al. Jun 2018 A1
20180221572 Schlitt et al. Aug 2018 A1
20180303720 Kennard et al. Oct 2018 A1
20190083357 David et al. Mar 2019 A1
20190117514 Denenburg et al. Apr 2019 A1
20190133885 Wu et al. May 2019 A1
20190343725 Denenburg Nov 2019 A1
20200093692 Lev et al. Mar 2020 A1
20200276084 Denenburg Sep 2020 A1
20200282133 Mason et al. Sep 2020 A1
20200330326 Merchant et al. Oct 2020 A1
20200376194 Fabrikant et al. Dec 2020 A1
Foreign Referenced Citations (237)
Number Date Country
2946559 Oct 2015 CA
1636605 Jul 2005 CN
1747683 Mar 2006 CN
1863566 Nov 2006 CN
1950049 Apr 2007 CN
101001661 Jul 2007 CN
101687083 Mar 2010 CN
106413799 Feb 2017 CN
306375580 Mar 2021 CN
1064693 Sep 1959 DE
1913926 Sep 1970 DE
4122476 Jan 1993 DE
4314657 Nov 1994 DE
4408498 May 1995 DE
19504413 Aug 1996 DE
202004012714 Nov 2004 DE
102007046951 Feb 2009 DE
202009011019 Dec 2010 DE
001680703 Mar 2010 EM
001126270-0001 Aug 2010 EM
001680703-0001 Aug 2010 EM
001680703-0002 Aug 2010 EM
002446062-0001 Aug 2010 EM
002446062-0002 Aug 2010 EM
000627237-0001 Oct 2010 EM
006630893-0001 Aug 2019 EM
008039507-0004 Jan 2021 EM
0192661 Sep 1986 EP
0195018 Sep 1986 EP
0258913 Mar 1988 EP
0416454 Mar 1991 EP
0426403 May 1991 EP
0282545 Feb 1992 EP
0518397 Dec 1992 EP
0521460 Jan 1993 EP
0582038 Feb 1994 EP
0598918 Jun 1994 EP
0637443 Feb 1995 EP
0737467 Oct 1996 EP
0761562 Mar 1997 EP
0765652 Apr 1997 EP
0765853 Apr 1997 EP
0806597 Nov 1997 EP
0814866 Jan 1998 EP
0829248 Mar 1998 EP
0856331 Aug 1998 EP
0882441 Dec 1998 EP
0887085 Dec 1998 EP
0887885 Dec 1998 EP
0897708 Feb 1999 EP
0898951 Mar 1999 EP
0960616 Dec 1999 EP
1008337 Jun 2000 EP
1029526 Aug 2000 EP
1034809 Sep 2000 EP
1051988 Nov 2000 EP
1323403 Jul 2003 EP
1329210 Jul 2003 EP
1396250 Mar 2004 EP
1454609 Sep 2004 EP
1454650 Sep 2004 EP
1498097 Jan 2005 EP
1872824 Jan 2008 EP
1911432 Apr 2008 EP
1919432 May 2008 EP
1930038 Jun 2008 EP
2090278 Aug 2009 EP
2351548 Aug 2011 EP
2351549 Aug 2011 EP
2462913 Jun 2012 EP
2512399 Oct 2012 EP
2416739 Jun 2016 EP
2029242 Oct 1970 FR
2856660 Dec 2004 FR
2869795 Nov 2005 FR
2931363 Nov 2009 FR
1444210 Jul 1976 GB
171662 Oct 2005 IL
186290 Jan 2008 IL
3310180010001 Jun 2001 IN
03-062426 Sep 1991 JP
03-205560 Sep 1991 JP
H03205560 Sep 1991 JP
04-329954 Nov 1992 JP
H04329954 Nov 1992 JP
06-050656 Jul 1994 JP
H0650656 Jul 1994 JP
08-000710 Jan 1996 JP
H08710 Jan 1996 JP
09-104460 Apr 1997 JP
09-104461 Apr 1997 JP
H09104461 Apr 1997 JP
10-118158 May 1998 JP
10-504736 May 1998 JP
11-503627 Mar 1999 JP
11-319031 Nov 1999 JP
H11319031 Nov 1999 JP
2000-508934 Jul 2000 JP
3062426 Jul 2000 JP
2000-237278 Sep 2000 JP
2000-262497 Sep 2000 JP
2001-505083 Apr 2001 JP
2002-035140 Feb 2002 JP
2002-516160 Jun 2002 JP
2002-355318 Dec 2002 JP
2003-033441 Feb 2003 JP
2003-102807 Apr 2003 JP
2003-513709 Apr 2003 JP
2004-501721 Jan 2004 JP
2004-097253 Apr 2004 JP
2004-522541 Jul 2004 JP
2004-267776 Sep 2004 JP
2005522282 Jul 2005 JP
2005-270629 Oct 2005 JP
2005-537048 Dec 2005 JP
2006-061421 Mar 2006 JP
2008-220961 Sep 2008 JP
2009-513294 Apr 2009 JP
4329954 Sep 2009 JP
2010-063622 Mar 2010 JP
2010-179128 Aug 2010 JP
2011015982 Jan 2011 JP
2012-205769 Oct 2012 JP
2013-520272 Jun 2013 JP
2014-000220 Jan 2014 JP
2014514114 Jun 2014 JP
2015-211763 Nov 2015 JP
3205560 Aug 2016 JP
2016527975 Sep 2016 JP
2019-015749 Jan 2019 JP
8601487 Mar 1986 WO
8601712 Mar 1986 WO
8605683 Oct 1986 WO
9003536 Apr 1990 WO
9403373 Feb 1994 WO
9507066 Mar 1995 WO
9507720 Mar 1995 WO
9513785 May 1995 WO
9600053 Jan 1996 WO
9609083 Mar 1996 WO
9629113 Sep 1996 WO
9736636 Oct 1997 WO
9832411 Jul 1998 WO
9837854 Sep 1998 WO
9961093 Dec 1999 WO
0102490 Jan 2001 WO
0128490 Apr 2001 WO
0130425 May 2001 WO
0132524 May 2001 WO
0160311 Aug 2001 WO
0189607 Nov 2001 WO
0191693 Dec 2001 WO
0202165 Jan 2002 WO
0209797 Feb 2002 WO
0232372 Apr 2002 WO
0236191 May 2002 WO
0266100 Aug 2002 WO
02066100 Aug 2002 WO
0289900 Nov 2002 WO
2002089900 Nov 2002 WO
0351423 Jun 2003 WO
0370147 Aug 2003 WO
03070147 Aug 2003 WO
0379956 Oct 2003 WO
2004004806 Jan 2004 WO
2004041148 May 2004 WO
2004096113 Nov 2004 WO
2005002492 Jan 2005 WO
2005018703 Mar 2005 WO
2005041846 May 2005 WO
2005105014 Nov 2005 WO
2005120431 Dec 2005 WO
2006099441 Sep 2006 WO
2006124634 Nov 2006 WO
2007015233 Feb 2007 WO
2007017868 Feb 2007 WO
2007052252 May 2007 WO
2007079305 Jul 2007 WO
2007101772 Sep 2007 WO
2007105221 Sep 2007 WO
2007130809 Nov 2007 WO
2008068756 Jun 2008 WO
2008076459 Jun 2008 WO
2008081424 Jul 2008 WO
2008126090 Oct 2008 WO
2008135989 Nov 2008 WO
2009026443 Feb 2009 WO
2009029010 Mar 2009 WO
2009038860 Mar 2009 WO
2009040804 Apr 2009 WO
2009087572 Jul 2009 WO
2009093249 Jul 2009 WO
2009112489 Sep 2009 WO
2009140511 Nov 2009 WO
2009146088 Dec 2009 WO
2010061743 Jun 2010 WO
2010078227 Jul 2010 WO
2010117471 Oct 2010 WO
2010117580 Oct 2010 WO
2011004360 Jan 2011 WO
2011024725 Mar 2011 WO
2011025719 Mar 2011 WO
WO-2011024725 Mar 2011 WO
2011039747 Apr 2011 WO
2011058545 May 2011 WO
2011058548 May 2011 WO
2011077434 Jun 2011 WO
2011090955 Jul 2011 WO
2011104711 Sep 2011 WO
2011132657 Oct 2011 WO
2011150037 Dec 2011 WO
2011156373 Dec 2011 WO
2012004784 Jan 2012 WO
2012004790 Jan 2012 WO
2012063230 May 2012 WO
2012143921 Oct 2012 WO
2012150587 Nov 2012 WO
2013001525 Jan 2013 WO
2013127813 Sep 2013 WO
2013134246 Sep 2013 WO
2013148435 Oct 2013 WO
2013156944 Oct 2013 WO
2013156994 Oct 2013 WO
2014033706 Mar 2014 WO
2014033710 Mar 2014 WO
2014099395 Jun 2014 WO
2014170888 Oct 2014 WO
2014174278 Oct 2014 WO
2015009746 Jan 2015 WO
2015019343 Feb 2015 WO
2016023590 Feb 2016 WO
2017203512 Nov 2017 WO
2018030481 Feb 2018 WO
2018104930 Jun 2018 WO
2018104932 Jun 2018 WO
2018178971 Oct 2018 WO
2020222220 Nov 2020 WO
Non-Patent Literature Citations (179)
Entry
Article with picture of West Pharmaceutical Services' Vial2Bag Needleless System, [on-line]; !Sips Newsletter, Oct. 26, 2007]; retrieved from Internet Feb. 16, 2010]; URL:<http://www.isips.org/reports/ISIPS_Newsletter_October_26_2007.html.> (7 pages. see pp. 5-6).
Chinese Patent Application No. 201330626512.5, filed on Dec. 16, 2013, by West Pharmaceutical Services, Inc.
Decision to Grant dated Apr. 12, 2010 in EP Application No. 08738307.1.
Drug Administration Systems product information sheets; http://www.westpharma.com/eu/en/products/Pages/Vial2Bag.aspx; pp. 1-3 (admitted prior art).
English translation of an Office Action dated Apr. 28, 2014 in JP Application No. 2013-537257.
English translation of an Office Action dated Aug. 28, 2014 in JP Application No. 2013-168885.
English translation of an Office Action dated Dec. 25, 2013 in CN Application No. 201180006530.1.
English translation of an Office Action dated Dec. 4, 2013 in CN Application No. 201080051210.3.
English translation of an Office Action dated Feb. 4, 2014 in JP Application No. 2012-554468.
English translation of an Office Action dated Jan. 9, 2014 in JP Application No. 2010-526421.
English translation of an Office Action dated Jul. 26, 2013 in JP Application No. 2012-538464.
English translation of an Office Action dated Jun. 19, 2013 in JP Application No. 2012-531551.
English translation of an Office Action dated Jun. 30, 2014 in CN Application No. 201180052962.6.
English translation of an Office Action dated Sep. 10, 2013 in JP Application No. 2012-554468.
Extended European Search Report dated Jun. 3, 2014 in EP Application No. 08781828.2.
Facebook “West Pharmaceutical Services, Inc.”, first available Oct. 21, 2014 (https://www.facebook.com/westpharma/photos/710246859056351)(2014).
Grifols Vial Adapter Product Literature, 2 pages, Jan. 2002.
http://www.knovel.com/web/portal/browse/display?.sub.--EXT.sub.--KNOVEL.su-b.—DISPLAY.sub.—bookid=1023&VerticalID=0 [retrieved on Feb. 9, 2011].
http://www.westpharma.com/en/products/Pages/Mixject.aspx (admitted prior art), [Retrieved on Aug. 8, 2012].
http://www.westpharma.com/eu/en/products/Pages/Vial2Bag.aspx; Drug Adminsitration Systems product information sheets pp. 1-3.
http://www.westpharma.com/eu/SiteCollectionDocuments/Recon/mixject%20produ- ct%20sheet.pfg: MIXJECT product information sheet pp. 1, Sep. 10, 2010.
Int'l Preliminary Report on Patenability dated Oct. 20, 2009 in Int'l Application No. PCT/IL2008/000517.
Int'l Preliminary Report on Patentability dated Jan. 14, 2014 in Int'l Application No. PCT/IL2012/050516.
Int'l Preliminary Report on Patentability dated May 6, 2008 in Int'l Application No. PCT/IL2006/001228.
Int'l Preliminary Report on Patentability dated May 12, 2014 in Int'l Application No. PCT/IL2013/050316.
Int'l Preliminary Report on Patentability dated Aug. 20, 2014 in Int'l Application No. PCT/IL2012/050407.
Int'l Preliminary Report on Patentability dated Aug. 28, 2012 in Int'l Application No. PCT/IL2011/000186.
Int'l Preliminary Report on Patentability dated Sep. 24, 2013 in Int'l Application No. PCT/IL2012/000354.
Int'l Preliminary Report on Patentability dated Dec. 4, 2007 in Int'l Application No. PCT/IL2006/000912.
Int'l Preliminary Report on Patentability dated Jun. 19, 2006 in Int'l Application No. PCT/IL2005/000376.
Int'l Preliminary Report on Patentability dated Jun. 19, 2008 in Int'l Application No. PCT/IL2007/000343.
Int'l Search Report & Written Opinion dated Mar. 7, 2012 in Int'l Application No. PCT/IL2011/000829.
Int'l Search Report and Written Opinion dated Mar. 6, 2012 in Int'l Application No. PCT/IL2011/000834.
Int'l Search Report and Written Opinion dated May 8, 2014 in Int'l Application No. PCT/IL2013/050706.
Int'l Search Report and Written Opinion dated Jul. 16, 2014 in Int'l Application No. PCT/IL2014/050327.
Int'l Search Report and Written Opinion dated Sep. 2, 2014 in Int'l Application No. PCT/IL2014/050405.
Int'l Search Report and Written Opinion dated Mar. 23, 2020 in Int'l Application No. PCT/IL2020/050048.
Int'l Search Report dated Feb. 3, 2011 in Int'l Application No. PCT/IL2010/000777; Written Opinion.
Int'l Search Report dated Mar. 17, 2011 in Int'l Application No. PCT/IL2010/000854; Written Opinion.
Int'l Search Report dated Mar. 17, 2011 in Int'l Application No. PCT/IL2010/000915; Written Opinion.
Int'l Search Report dated Mar. 18, 2013 in Int'l Application No. PCT/IL2012/050516.
Int'l Search Report dated Jun. 5, 2013 in Int'l Application No. PCT/IL2012/050407.
Int'l Search Report dated Jun. 19, 2013 in Int'l Application No. PCT/IL2013/050167.
Int'l Search Report dated Jul. 1, 2013 in Int'l Application No. PCT/IL2013/050180.
Int'l Search Report dated Jul. 26, 2013 in Int'l Application No. PCT/IL2013/050316.
Int'l Search Report dated Jul. 31, 2013 in Int'l Application No. PCT/IL2013/050313.
Int'l Search Report dated Aug. 16, 2012 in Int'l Application No. PCT/IL2012/000164.
Int'l Search Report dated Oct. 17, 2005 in Int'l Application No. PCT/IL2005/000376.
Int'l Search Report dated Oct. 17, 2011 in Int'l Application No. PCT/IL2011/000511.
Int'l Search Report dated Nov. 25, 2010 in Int'l Application No. PCT/IL2010/000530.
Smart Site Needle-Free Systems, Alaris Medical Systems Webpage, 4 pages, Feb. 2006.
Smart Site.RTM. Alaris Medical Systems Product Brochure, 4 pages, Issue 1, Oct. 1999.
Summit International Medical Technologies Inc., Vial Direct to Bag Spike 2020.
The MixJect transfer system, as shown in the article, “Advanced Delivery Devices,” Drug Delivery Technology Jul./Aug. 2007 vol. 7 No.7 [on-line]. [Retrieved from Internet May 14, 2010.] URL: <http://www.drugdeiverytech-online.com/drugdelivery/200707/?pg=28pg28>. (3 pages).
Translation of Office Action dated Apr. 15, 2013 in JP Application No. 2008-538492.
Translation of Office Action dated Jun. 18, 2012 in JP Application No. 2008-538492.
U.S. Appl. No. 14/005,751 by Denenburg, filed Sep. 17, 2013.
U.S. Appl. No. 13/505,790 by Lev, filed May 3, 2012.
U.S. Appl. No. 13/505,881 by Lev, filed May 3, 2012.
U.S. Appl. No. 13/522,410 by Lev, filed Jul. 16, 2012.
U.S. Appl. No. 13/576,461 by Lev, filed Aug. 1, 2012.
U.S. Appl. No. 13/883,289 by Lev, filed May 3, 2013.
U.S. Appl. No. 13/884,981 by Denenburg, filed May 13, 2013.
U.S. Appl. No. 14/345,094 by Lev, filed Mar. 14, 2014.
U.S. Appl. No. 14/366,306 by Lev, filed Jun. 18, 2014.
U.S. Appl. No. 14/385,212 by Lev, filed Sep. 15, 2014.
U.S. Appl. No. 14/391,792 by Lev, filed Oct. 10, 2014.
U.S. Appl. No. 14/423,595 by Lev, filed Feb. 24, 2015.
U.S. Appl. No. 14/423,612 by Lev, filed Feb. 24, 2015.
U.S. Appl. No. 14/425,582 by Lev, filed Mar. 3, 2015.
U.S. Appl. No. 14/504,979 by Lev, filed Oct. 2, 2014.
U.S. Appl. No. 14/784,300 by Lev, filed Oct. 14, 2015.
U.S. Appl. No. 14/888,590 by Marks, filed Nov. 2, 2015.
U.S. Appl. No. 29/438,134 by Lev, filed Nov. 27, 2012.
U.S. Appl. No. 29/438,141 by Gilboa, filed Nov. 27, 2012.
U.S. Appl. No. 29/478,723 by Lev, filed Jan. 8, 2014.
U.S. Appl. No. 29/478,726 by Lev, filed Jan. 8, 2014.
U.S. Appl. No. 29/502,037 by Lev, filed Sep. 11, 2014.
U.S. Appl. No. 29/502,053 by Lev, filed Sep. 11, 2014.
U.S. Appl. No. 29/544,969 by Ben Shalom, filed Nov. 9, 2015.
Vial-Mate Adapter Device, Baxter, May 2017, downloaded from web page:http://www.baxtermedicationdeliveryproducts.com/drug-delivery/vialmate.html, Download Date: Jul. 28, 2017, original posting date: unknown, 1page.
Voutube.com, Vial2Bag DC, Aug. 21, 2014, https://www.youtube.com/watch?v=FEOkglxNBrs.
West Vial2Bag DC system, Oct. 2, 2014, https://web.archive.org/web/2014002065133/http://www.westpharma.com/en/products/Pages/Reconstitutionsystems.aspx.
Written Opinion dated Aug. 16, 2012 in Int'l Application No. PCT/IL2012/000164.
Written Opinion dated Jul. 31, 2013 in Int'l Application No. PCT/IL2013/050313.
Written Opinion dated Jun. 5, 2013 in Int'l Application No. PCT/IL2012/050407.
Written Opinion of ISR dated Jun. 19, 2006 in Int'l Application No. PCT/IL2005/000376.
Written Opinion of the ISR dated Oct. 17, 2009 in Int'l Application No. PCT/IL08/00517.
Youtube, “ADVCARE—Vial Direct to bag Spoke”, first available Oct. 31, 2018 (https://www.youtube.com/watch?v=dd8ctggkrfM&feature=emb_title)(2018).
Youtube, “vial2Bag DC”, first available Feb. 1, 2018, (https://www.youtube.com/watch?v=abSKPo5e_Hg) (Year:2018).
Youtube, “Vial2Bag.RTM. Needleless IV Transfer System from Helapet Ltd”, first available Aug. 21, 2014 (https://www.youtube.com/watch?v=yFejsv0eemE) (Year: 2014).
Int'l Search Report and Written Opinion dated May 6, 2008 in Int'l Application No. PCT/IL2006/001228.
Office Action dated Aug. 7, 2015 in JP Application No. 2015-529206.
Office Action dated Dec. 13, 2010 in U.S. Appl. No. 12/293,122.
Office Action dated Dec. 20, 2010 in U.S. Appl. No. 12/063,176.
Office Action dated Dec. 23, 2010 in U.S. Appl. No. 29/334,696.
Office Action dated Dec. 9, 2015 in U.S. Appl. No. 29/478,723 by Lev.
Office Action dated Dec. 9, 2015 in U.S. Appl. No. 29/478,726 by Lev.
Office Action dated Feb. 13, 2014 in U.S. Appl. No. 13/884,981 by Denenburg.
Office Action dated Feb. 20, 2009 in U.S. Appl. No. 11/694,297.
Office Action dated Feb. 22, 2005 in U.S. Appl. No. 10/062,796.
Office Action dated Feb. 7, 2011 in U.S. Appl. No. 12/783,194.
Office Action dated Jan. 17, 2014 in CN Application No. 201180006534.X.
Office Action dated Jan. 2, 2014 in U.S. Appl. No. 13/505,881 by Lev.
Office Action dated Jan. 2, 2015 in U.S. Appl. No. 29/438,141 by Gilboa.
Office Action dated Jan. 20, 2010 in JP Application No. 2007-510229.
Office Action dated Jan. 23, 2013 in U.S. Appl. No. 12/112,490 by Zinger.
Office Action dated Jan. 5, 2015 in U.S. Appl. No. 29/413,220 by Lev.
Office Action dated Jul. 11, 2011 in U.S. Appl. No. 12/293,122.
Office Action dated Jul. 13, 2012 in U.S. Appl. No. 12/112,490 by Zinger.
Office Action dated Jul. 31, 2014 in U.S. Appl. No. 29/438,141 by Gilboa.
Office Action dated Jun. 1, 2010 in U.S. Appl. No. 11/568,421.
Office Action dated Jun. 14, 2012 in U.S. Appl. No. 29/376,980.
Office Action dated Jun. 15, 2011 in JP Application No. 2008-538492.
Office Action dated Jun. 15, 2012 in U.S. Appl. No. 29/413,170.
Office Action dated Jun. 21, 2012 in U.S. Appl. No. 12/596,167.
Office Action dated Jun. 8, 2010 in U.S. Appl. No. 12/112,490 by Zinger.
Office Action dated Mar. 1, 2012 in CN Application No. 200880108283.4.
Office Action dated Mar. 10, 2015 in EP Application No. 12 812 395.7.
Office Action dated Mar. 13, 2012 in CA Application No. 2,563,643.
Office Action dated Mar. 17, 2015 in U.S. Appl. No. 14/504,979 by Lev.
Office Action dated Mar. 25, 2016 in U.S. Appl. No. 29/478,726 by Lev.
Office Action dated Mar. 28, 2016 in JP Application No. 2016-507113.
Office Action dated Mar. 6, 2012 in U.S. Appl. No. 12/678,928.
Office Action dated May 12, 2011 in U.S. Appl. No. 12/063,176.
Office Action dated May 27, 2010 in U.S. Appl. No. 11/559,152.
Office Action dated May 28, 2015 in U.S. Appl. No. 14/391,792 by Lev.
Office Action dated May 31, 2013 in U.S. Appl. No. 13/505,790.
Office Action dated May 6, 2014 in U.S. Appl. No. 13/505,881 by Lev.
Office Action dated Nov. 11, 2013 in IL Application No. 218730.
Office Action dated Nov. 28, 2013 in IN Application No. 4348/DELNP/2008.
Office Action dated Nov. 29, 2010 in U.S. Appl. No. 11/568,421.
Office Action dated Oct. 5, 2005 in U.S. Appl. No. 10/062,796.
Office Action dated Oct. 5, 2015 in U.S. Appl. No. 14/385,212 by Lev.
Office Action dated Oct. 6, 2003 in U.S. Appl. No. 10/062,796.
Office Action dated Oct. 8, 2013 in CN Application No. 201080043825.1.
Office Action dated Sep. 28, 2010 in U.S. Appl. No. 12/112,490 by Zinger.
Office Action dated Jul. 31, 2012 in U.S. Appl. No. 12/598,469.
Office Action dated May 25, 2021 issued in Japanese Application No. 2020-553506.
Overview—Silicone Rubber [retrieved from http://www.knovel.com/web/portal/browse/display?_EXT_KNOVEL_DISPLAY_bookid=1023&Vertica11D=0 on Feb. 9, 2011].
Photographs of Alaris Medical Systems SmartSite.RTM. device, 5 pages, 2002.
Publication dale of Israeli Patent Application 186290 [on-line]. ]Retrieved from Internet May 24, 2010]. URL:<http://www.ilpatsearch.justrice.gov.il/UI/Requestslistaspx>. (1 page).
Int'l Search Report dated Mar. 12, 2009 in Int'l Application No. PCT/IL2008/001278.
Int'l Search Report dated Mar. 27, 2009 in Int'l Application No. PCT/US2008/070024.
Int'l Search Report dated Jul. 12, 2011 in Int'l Application No. PCT/IL2011/000186.
Int'l Search Report dated Jul. 12, 2011 in Int'l Application No. PCT/IL2011/000187.
Int'l Search Report dated Jul. 27, 2007 in Int'l Application No. PCT/IL2007/000343.
Int'l Preliminary Report on Patentability dated Aug. 24, 2015 in Int'l Application No. PCT/IL2014/050405.
Int'l Search Report and Written Opinion dated Jul. 21, 2020 in Int'l Application No. PCT/IL2020/050362.
Int'l Search Report and Written Opinion dated Mar. 29, 2019 in Int'l Application No. PCT/IB2018/059577.
Int'l Search Report and Written Opinion dated May 4, 2011 in Int'l Application No. PCT/IL2010/001077.
Int'l Search Report dated Apr. 24, 2020 in Int'l Application No. PCT/US2020/050020.
Int'l Search Report dated Aug. 25, 2008 in Int'l Application No. PCT/IL2008/000517.
Int'l Search Report dated Dec. 6, 2006 in Int'l Application No. PCT/IL2006/000912.
Int'l Search Report dated Jan. 22, 2013 in Int'l Application No. PCT/IL2012/000354.
Int'l Search Report dated Nov. 20, 2006 in Int'l Application No. PCT/IL2006/000881.
International Search Report and Written Opinion dated Oct. 17, 2014 in International Application No. PCT/IL2014/050680.
International Search Report dated Jan. 23, 2007 in Int'l Application No. PCT/IL/2006/001228.
International Search Report dated Mar. 30, 2011 in Int'l Application No. PCT/IL2010/000939.
International Search Report dated Aug. 28, 2008 in Int'l Application No. PCT/IL2008/000606.
IV disposables sets catalogue, Cardinal Health, Alaris(Registered) products, SmartSite(Registered) access devices and accessories product No. 10013365, SmartSite add-On bag access device with spike adapter and needle-free valve bag access port, pp. 1-5, Fall edition (2007).
Kipp, “Plastic Material Data Sheets,” retrieved from the Internet: http://www.knovel.com/web/portal/browse/display?EXT_KNOVEL_DISPLAY_bookid=1023&VerticalID=0, retrieved on Feb. 9, 2011.
Merchant “An engineered control device for needle free reconstitution and transfer of compounded sterile intravenous Drug solutions for immediate use to assist in complying with United States Pharmacopeia Chapter <797> standard”, Adv Care, 2 pages, 2018.
MixJect, downloaded from webpage: http://www.westpharma.com/en/products/Pages/MixjecLaspx, Download Date: Aug. 8, 2012, 1 page.
MixJet Product Information Sheet, downloaded from webpage: http://www.westpharma.com/SiteCollectionDocuments/Recon/mixject%20product%20sheet.pdf; 1 page.
Non-Vented Vial Access Pin with ULTRASITE.RM. Valve, B. Braun Medical, Inc. website and product description, 3 pages, Feb. 2006.
Notice of Allowance dated Jan. 12, 2016 in U.S. Appl. No. 14/385,212 by Lev.
Notice of Allowance dated Mar. 17, 2016 in U.S. Appl. No. 29/502,037 by Lev.
Novel Transfer, Mixing and Drug Delivery System, MOP Medimop Medical Projects Ltd. Catalog, 4 pages, Rev. 4, 2004.
Office Action dated Apr. 17, 2014 in CN Application No. 201080051201.4.
Office Action dated Apr. 2, 2013 in U.S. Appl. No. 13/505,790.
Office Action dated Apr. 20, 2010 in U.S. Appl. No. 11/997,569.
Office Action dated Apr. 9, 2015 in U.S. Appl. No. 13/883,289 by Lev.
Office Action dated Aug. 20, 2013 in U.S. Appl. No. 13/576,461 by Lev.
Office Action dated Aug. 24, 2015 in U.S. Appl. No. 14/366,306 by Lev.
Office Action dated Aug. 3, 2011 in JP Application No. 2008-525719.
Author unknown, Progressive Medical inc. is proud to announce the launch of West's Vial2Bag Agvanced, Progressive Medinc ., [Post Date Oct. 23, 2020], [Site seen Jan. 25, 2022], Seen at URL: https://www.progressivemedinc.com/west-launches-vial2bag-advanced-20mm-admixture-device/ (Year: 2020).
Our Vial2Bag Advanced™ 20mm admixture device , West Pharma, WestPharma @twitter, [Postdate 3/19/021], [Siteseen Jan. 25, 2022], Seen at URL: https://twitter.com/westpharma/status/1372921057766739971 (Year: 2021).
Vial2Bag Advanced™ 20mm Admixture , West Pharmaceutical Services Inc, Youtube, [post date Nov. 5, 2020], [Site seen Jan. 25, 2022], Seen at URL: https://www.youtube.com/watch?v=J0Am3mt5vn8 (Year: 2020).
Related Publications (1)
Number Date Country
20230052165 A1 Feb 2023 US
Provisional Applications (1)
Number Date Country
62840620 Apr 2019 US
Continuations (1)
Number Date Country
Parent 16982410 US
Child 17953321 US